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The binding of various alkylguanidines to the histrioni-
cotoxin site of the membrane bound acetylcholine receptor of 
Torpedo californica was studied. These results, along with 
data obtained on the binding of several histrionicotoxin 
derivatives, were used to formulate a model of ligand to 
binding to the receptor's histrionicotoxin site. 
An azido derivative of histrionicotoxin was used in 
an attempt to photoaffinity label the histrionicotoxin site. 
The effect of the agonist carbamylcholine on incorporation 




Proton magnetic resonance was used to monitor binding of 
choline, a known partial agonist, to acetylcholine receptor-
enriched membrane preparations from Torpedo californica electro-
plax. The interaction between choline and receptor led to a 
broadening of the resonance of the choline methyl groups and 
this effect was reversed by a-bungarotoxin, a quasi-irreversible 
antagonist of the acetylcholine receptor. From the concentration 
dependence of line broadening the equilibrium dissociation 
constant for choline was obtained (Kd = 190 ~ 65 µM). The 
temperature dependence of the parameters observed in the choline 
titrations gave an enthalpy of binding LH < 1.5 kcal/mol and 
allowed estimates for the dissociation rate constant of the 
receptor-choline complex (kd. > 1.6 x 10 3 S 1 ) and the 
. lSS 
respective activation energy, Ea (kdiss) ~ 5.5 kcal/mol. The 
association of other ligands with the membrane-bound receptor 
could also be studied by observing effects of varying concen-
trations of such ligands on the choline methyl group linewidth 




Membrane fragments from the electric organ of Torpedo 
californica were purified so that the only protein components 
remaining were the four homologous acetylcholine receptor 
subunits of 40,000, 50,000, 60,000 and 65,000 daltons. The 
change in agonist affinity induced by carbamylcholine and the 
rate of this change, especially in the presence of local 
anesthetics, were studied and compared to the corresponding 
properties of membranes containing additional protein components. 
The results were consistent with the notion that desensitization, 
as defined by conversion to a state of higher ligand affinity of 
the acetylcholine receptor, and modulation of the kinetics of 
this effect by local anesthetics are dependent only on the 
receptor protein in its native environment. 
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INTRODUCTION 
Early studies in microanatomy (Ramon y Cajal, 1894, 
Auerbach, 1898) demonstrated that there is no direct contact 
between the nerve ending and the muscle to which the nerve 
carries information. This gap, or synaptic space (Foster and 
Sherrington, 1897), implies that the electrical depolarization 
propagated along the nerve is not directly transferred to the 
muscle as an electrical impulse, per se, but rather that a 
separate mechanism exists to bridge the gap, which is 200-500 A 
wide. After several decades of research by biochemists and 
electrophysiologists, the transmission of the nerve impulse 
across the synapse is known to be mediated chemically. The 
depolarization of the nerve terminal by a nerve impulse induces 
the release of acetylcholine, which diffuses across the gap 
and binds to the acetylcholine receptor protein (AcChR). This 
binding causes the opening of ion channels in the postsynaptic 
membrane. The resulting influx of sodium ions depolarizes the 
postsynaptic membrane and generates an end plate potential, 
which leads to events culminating in contraction of the muscle. 
Depolarization of the presynaptic membrane results in an 
influx of calcium ions. These calcium ions cause the fusion 
of many presynaptic vesicles with the presynaptic membrane 
(Rahamimoff, et al., 1975). These vesicles each contain 10 3-
105 molecules of acetylcholine and this acetylcholine is 
released into the synaptic space when the vesicles fuse with 
the membrane. In the absence of a nerve impulse presynaptic 
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vesicles occasionally and randomly fuse with the postsynaptic 
membrane, which results in miniature end plate potentials (MEPP) 
of about 0.5 mV. These are far below the firing threshold 
of the muscle (Katz, 1971) but are detectable 
electrophysiologically and have been an important source of 
information in investigations of the synapse (Stevens, 1975). 
A nerve impulse results in the fusion of a large number of 
vesicles with the membrane and sufficient acetylcholine is 
released to trigger a full end plate potential in the post 
synaptic membrane. This end plate potential is sufficiently 
large to trigger an action potential which propagates down 
the muscle fiber. The synapse is subsequently cleared of acetyl-
choline by the acetylcholinesterase, which hydrolyses acetyl-
choline into acetate and choline. 
The key event on the postsynaptic side is in converting 
the chemical signal back into an electrical one. The binding 
of acetylcholine to the AcChR must cause an increase in the 
postsynaptic membrane permeability to sodium ions, which 
probably pass through an ion channel. The structure of this 
channel and the mechanism by which the binding of acetylcholine 
opens the channel are just beginning to be understood. 
The discovery that a-Bungarotoxin binds specifically and 
essentially irreversibly to the AcChR, blocking AcCh binding 
(Lee and Chang, 1966; Lee, et al., 1967), was the breakthrough 
that allowed isolation of the AcChR. The toxin is a small 
peptide which was isolated from the venom of the banded krait 
Bungarus multicirtctus. Well known methods of protein chemistry 
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allowed labeling of the a-BuTx with l25r or a fluorophore 
(Barnard, et al., 1971; Berg, et al., 1972; Barrantes, 
et al., 1975) and demonstrated that the AcChR 
is located exclusively on the postsynaptic side of the synapse. 
The membrane is highly folded in this region and the AcChR was 
shown to be concentrated at the crests of the folds at densities 
of 2 - 2.5 x 10 4 /µm 2 (Barnard, et al., 1975). The cholinesterase 
is evenly distributed along the folds (Salpeter, et al., 1972). 
Isolation of the AcChR was also simplified with the 
discovery that the electric organs of Torpedo and Electrophorus 
are rich sources of the protein. These electric organs are 
modified muscle tissue with large numbers of synapses (Bennett, 
1970). The organs constitute a substantial fraction of the 
total weight of the fish; a 15 Kg Torpedo has approximately 3 Kg 
of electric organs, one located in each of its two lobes. On a 
cellular level, the organs are composed of stacks of large 
cells known as electroplaques. The ventral face of an electro-
plaque is heavily innervated, with up to fifty percent of the 
membrane area covered by synapses in Torpedo and perhaps two 
percent of the membrane in the case of Electrophorus (Bourgeois, 
et al., 1972). Typically, the higher density of synapses in 
Torpedo makes them the source of choice for isolating AcChR, 
while the larger size of electroplaques from Electrophorus favors 
them as a source for electrophsiological studies with intact 
cells. The Electophorus electroplaques are large enough to 
allow isolation and mounting of a single cell between extra-
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cellular electrodes and thus the effects of bath applied drugs 
may be investigated (Schoeffeniels and Nach~ansohn, 1957). 
Historically the AcChR was first isolated as a detergent 
solubilized complex with radioactively labeled a-BuTx (Miledi, 
et al., 1971; Raftery, et al., 1972; Clark, et al., 1972; 
Eldefrawi and Eldefrawi, 1972). The protocols established in 
these studies soon led to isolation of the solubilized free 
AcChR from several species of Torpedo (Raftery, et al., 1973; Schmidt 
and Raftery, 1973; Eldefrawi and Eldefrawi, 1975; Karlin and Coburn , 
1973; Ong and Brady, 1974; Weill, et al., 1974), Narcine 
(Schmidt and Raftery, 1972), and Electrophorus (Biesecker, 1973; 
Klett, et al., 1973; Chang, 1974; Lindstrom and Patrick, 1974; 
Meunier, et al., 1974) using affinity chromatography. Most of 
these early isolations reported the presence of a protein of 
40,000 daltons molecular weight, although there was little 
agreement beyond this as to the subunit composition of the AcChR. 
Proteolysis appears to have been the major reason for these 
differences (Vandlen, et al., 1976) and it has now been 
established that the AcChR from Torpedo is composed of subunits 
of molecular weights 40,000, 50,000, 60,000, and 65,000 daltons 
(Raftery, et al., 1974; Weill, et al., 1974; Vandlen, et al., 
1976), with a respective subunit stoichiometry of 2:1:1:1 as 
determined by N-terminal amino acid analysis (Strader, et al., 
1980). This stoichiometry leads to a molecular weight of 
255,000 daltons, which compares well with the values of 250,000 
daltons determined for Torpedo using sedimentation velocity 
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centrifugation corrected for bound detergent using D2 0 
(Reynolds and Karlin, 1978), 270,000 daltons using membrane 
osmometry (Martinez-Carrion, et al., 1975), and 270,000 daltons 
calculated by SDS electrophoresis of cross-linked AcChR 
(Biesecker, 1973; Hucho, et al., 1978). Other sedimentation 
determinations have reported molecular weights of between 
250,000 and 330,000 daltons, but these are complicated by the 
difficulty in determining the amount of detergent bound to the 
protein (Raftery, et al., 1972; Edelstein, et al., 1975). 
The detergent solubilized AcChR exists as both monomer 
and dimer with 9S and 13.7S sedimentation coefficients (Raftery, 
et al., 1972). Both have similar ligand binding properties 
(Raftery, et al., 1972; Sugiyama and Changeux, 1975; Gibson, 
et al., 1976). The dimer is formed by a disulfide bond between 
the 65,000 dalton subunits of two monomers (Chang and Bock, 
1977; Hamilton, et al., 1977; Witzemann and Raftery, 1978a; 
Hucho, et al. , 1978) .. 
The unusually high concentration of AcChR in the post-
synaptic membrane clefts allows isolation of almost pure AcChR 
in its native membrane environment. Homogenization of the 
Torpedo electroplaques results in membrane fragments, a sub-
stantial percentage of which are derived from the synaptic 
clefts. Fragments from the synaptic clefts are of higher 
density than extra-synaptic cleft fragments due to the densely 
packed AcChR they contain. This allows isolation of the 
membrane-bound AcChR by sucrose density centrifugation (Cohen, 
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et al., 1972; Duguid and Raftery, 1973). Subsequent removal 
of the extrinsic membrane proteins using alkali (Steck and Yu, 
1973) results in preparations of AcChR bound to its native 
membrane substantially free of contaminating proteins (Neubig, 
et al., 1979; Elliott, et al., 1980). These AcChR enriched 
membrane fragments have been valuable in investigating ligand 
binding and in vitro flux of ions through the AcChR ion 
channels. 
These membrane preparations have also been used in 
structural studies of the AcChR. Electron microscopy of the 
preparations demonstrated large arrays of densely packed 
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rosettes, each about 90 A in diameter (Nickel and Potter, 
1973; Cartaud, et al., 1973; Raftery, et al., 1974), which were 
positively identified as AcChR (Klymkowsky and Stroud, 1979). 
Low angle X-ray studies of the Torpedo membrane fragments 
demonstrated that the AcChR spanned the membrane (Ross, et al., 
1977), a fact which was recently confirmed by using anti-
receptor antibodies on sealed membrane vesicles (Strader, et al., 
1979). Lactoperoxidase catalysed 125 I labeling of AcChR 
enriched membrane fragments (Hartig and Raftery, 1977) has shown 
that at least the 40,000, 50,000, and 60,000 dalton subunits 
are exposed to the solvent. 
The membrane-bound AcChR preparations have the same subunits 
as the affinity chromatography purified receptor in addition to 
bands of 43,000 and 90,000 daltons and small amounts of other 
proteins. These two proteins are removed by the alkali treatment 
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and do not serve any known AcChR function (Elliott, et al., 
1980; Neubig, et al., 1979; Wu and Raftery, 1980). 
The ligand binding properties of the membrane-bound AcChR 
are considerably different than those of the detergent solubil-
ized preparations. The binding of [ 12 51]-a-BuTx to the 
membrane-bound AcChR of Torpedo has been shown to follow 
kinetics which can be described by a simple biomolecular 
mechanism (Weber and Changeux, 1974; Colquhoun and Rang, 1976; 
Weiland, et al., 1976); Blanchard, et al., 1979a). This 
indicates one homogeneous class of toxin binding sites. a-BuTx 
binding to the Triton X~lOO solubilized purified AcChR is more 
complicated, as biphasic kinetics were seen (Blanchard, et al., 
1979a). This implied either two classes of toxin sites or 
negative cooperativity (Blanchard, et al., 1979a). The rate 
of a-BuTx binding to solubilized AcChR was also much faster. 
Both solubilized and membrane-bound AcChR preparations 
bind cholinergic ligands, though as with a-BuTx,the two forms 
have significantly different properties. This difference is 
especially noticeable in the phenomenon known as desensitization. 
Densensitization is the term coined for the observation 
that prolonged exposure of the in vivo neuromuscular junction 
to agonists, which are defined as compounds that induce a 
depolarization of the postsynaptic membrane, decreases the 
effectiveness of the agonists in eliciting an electrical 
response (Katz and Thesleff, 1957). This observation can be 
explained by a two state model, in which an AcChR state with 
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low ligand affinity slowly converts to one of high agonist 
affinity due to the influence of agonist (Katz and Thesleff, 
1957). The in vivo agonist-induced affinity state change also 
results in increased affinity for some antagonists (Rang and 
Ritter, 1969; 1970b) and therefore the high affinity state 
is not ligand specific·. The affinity state change has also 
been observed in vitro using preparations of membrane-bound 
AcChR (Weber, et al., 1975; Colquhoun and Rang, 1976; Weiland, 
et al., 1976; Lee, et al., 1977). A quantitative explanation 
of in vitro carbamylcholine binding to AcChR requires a model 
more complex than the two state one of Katz and Thesleff 
(Quast, et al., 1978b, Dunn, et al., 1980). Triton X-100 
solubilized AcChR does not undergo reversible affinity state 
changes upon exposure to agonist (Vandlen, et al., 1976) possibly 
indicating that the membrane is important in forming or main-
taining receptor conformation. 
Attempts have been made to develop kinetic models of 
agonist binding to membrane bound AcChR using fluorescent 
probes in conjunction with stopped-flow spectroscopy. The 
change in intrinsic fluorescence of the AcChR upon ligand 
binding is quite small, but it has been used to observe a 
slow conformation change upon addition of agonist said to 
represent desensitization (Bonner, et al., 1976; Barrantes, 
1976). Extrinsic fluorescent probes result in large 
signals and hence better ability to observe subtle changes 
in conformation, but the hydrophobic nature of these probes 
leads to complications when they unavoidably partition 
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to some extent into the membrane. Perturbations induced by the 
probe itself are also a problem. Quinacrine was used as a 
membrane fragment probe and demonstrated two processes upon 
addition of agonist; one which was thought to represent receptor 
activation (Griinhagen, et al., 1977b) and a slower one which 
was attributed to desensitization (Griinhagen, 1976; Griinhagen, 
et al., 1977a). However, quinacrine is now known to act as 
a local anesthetic and these kinetic data therefore are suspect. 
Ethidium bromide has also been used to study agonist 
binding (Schimerlik, et al., 1979a,b; Quast, et al., 1978a). 
It does not act as a local anesthetic and data collected using 
it could best be explained using a sequential binding model 
(Quast, et al., 1978a; Quast, et al., 1979). Fluorescent 
acetylcholine analogs have also been used (Jiirss, et al., 
1979; Heidmann, et al., 1978), as has a method of covalently 
attaching a fluorescent label near the agonist site (Dunn, 
et al., 1980). 
Local anesthetics are known to block the normal in vivo 
response of the AcChR to agonists. On the basis of electro-
physiological evidence it has been proposed that local anesthe-
tics bind to the open channel form of the AcChR, decreasing 
conductance (Ruff, 1976; Neher and S·akman, 1976). Local 
anesthetics also increase the rate of desensitization in vivo 
(Magazanik and Vyskocil, 1973; Magazanik, 1976). In vitro 
studies with local anesthetics have demonstrated that they 
are weakly competitive with a-BuTx (Weber and Changeux, 1974; 
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Weiland, et al., 1977; Blanchard, et al., 1979b) and with 
perhydrohistrionicotoxin (Blanchard, et al., 1979b). Local 
anesthetics also affect the rate of in vitro agonists induced 
desensitization in the membrane-bound AcChR with varying 
magnitudes. The magnitudes approximately correlate with the 
binding of a given local anesthetic with the high or the low 
affinity forms of the AcChR (Blanchard, et al., 1979b). The 
nature of the local anesthetic binding site is not known, so 
it is difficult to do more than speculate about the mechanism 
of local anesthetic effects on the rate of desensitization. 
Procaine amide azide, a local anesthetic analog, was used as a 
photoaffinity label of the membrane-bound AcChR (Blanchard and 
Raftery, 1979) and results obtained with this analog are 
discussed below. 
The histrionicotoxins are another class of ligands that 
bind to the AcChR. Histrionicotoxins were first isolated 
from methanolic extracts of the skin of the South American 
"poison arrow" frog, Dendrobates histrionicus (Daly, et al., 
1971). The crude venom from these frogs is a mixture of 
alkaloids, one class of which is the histrionicotoxins, typified 
by an eleven carbon atom [5.5] azaspiro structure substituted 
in two positions with a 5 carbon atom and a 4 carbon atom side 
chain. The various histrionicotoxins differ in the degree of 
saturation of these side chains (Fig. I) (Tokuyama, et al., 
1974) with little difference in biological activity between 
them (Albuquerque, et al., 1973a,b), The toxins are well 
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Figure 1. The Histrionicotoxins 
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HTX: R1 = -CH=CH-C-CH, Ri = -CH2CH=CH-C=CH 
H2-HTX: R1 = -CH=CH-C=CH, Ri = -CH2CH2CH=C=CH2 
H 8-HTX: R1 = -CH2CH2CH=CH2 , ~ = -CH2CH2 CH2CH=CH2 
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characterized chemically (Daly, et al., 1971; Tokuyama, et al., 1974) 
and the X-ray structures of the two major forms present in the 
venom have been reported (Daly, et al., 1971; Karle, 1973). 
Both H 1 2 -HTX (Corey, et al. , 1975a) and H 1 0 -HTX ( Fukuyama, et al., 
1975) have been synthesized in the laboratory. 
The first electrophysiological studies with HTX (Albuquerque, 
et al., 1973a,b) found that it did not cause depolarization of 
the postsynaptic membrane, rather the toxin was found to block 
depolarization induced by application of AcCh and also that 
induced by indirect electrical stimulation~ This blockade was 
reversible. Further studies found that the H12 -HTX concentra-
tions necessary for half-maximal blockade of the rat muscle 
endplate potentials and extrajunctional AcCh sensitivity were 
8.4 µMand 2.4 µM respectively (Dolly, et al., 1977). H12 -HTX 
blocks a-BuTx binding only at concentrations more than a 
hundred-fold higher than these. An elaborate body of further 
electrophysiological data has been accumulated (Albuquerque, 
et al., 1975; Lapa, et al., 1975). 
The effects seen with HTX electrophysiologically are 
reminiscent of those seen with certain local anesthetics and 
it has been proposed (Kato and Changeux, 1976) that HTX and 
these local anesthetics have the same mode of action, namely 
that they increase the rate of agonist induced desensitization 
without causing desensitization in and of themselves (Magazanik 
and Vyskocil, 1973). It has also been proposed (Albuquerque, 
et al., 1973a,b) that HTX interacts with the open-channel form 
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of the AcChR, blocking the ion channel. This last hypothesis 
is tantalizing as it implies that HTX is a possible probe of 
the ion channel. As no other ion channel probe is known, HTX 
has been the subject of research in several laboratories 
(Eldefrawi, et al., 1975; Elliott and Raftery, 1977; Elliott 
and Raftery, 1979). It has been found that Carb causes a slight 
increase in the affinity of the membrane-bound AcChR for HTX 
(Elliott and Raftery, 1977) and HTX increased AcChR affinity 
for AcCh (Kato and Changeux, 1976). Most importantly, in view 
of the above two hypotheses, HTX did not increase the rate of 
Carb induced desensitization of membrane-bound AcChR (Elliott, 
et al., 1979). Solubilization of the AcChR destroyed HTX 
binding activity, although this activity could be regained from 
cholate extracts of AcChR enriched membrane fragments if the 
detergent concentration was diluted below the critical micelle 
concentration (Elliott and Raftery, 1979). 
The ultimate biological function of the AcChR is to allow 
a controlled influx of sodium ions through the postsynaptic 
membrane, hence reproducing this function in vitro with a 
system of well defined protein and lipid componen~s is a 
necessary step toward developing a full understanding of the 
AcChR mechanism. 
A large fraction of the AcChR enriched membrane fragments 
isolated from the sucrose density gradients are intact vesicles. 
These vesicles can be loaded with 22 Na+ and have sufficient func-
tional integrity that agonist induced 22 Na+ efflux through 
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the ion channel can be monitored through use of a filter assay 
(Kasai and Changeux, 1971; Michaelson and Raftery, 1974; 
Hazelbauer and Changeux, 1974; Popot, et al., 1976; Hess and 
Andrews, 1977; Miller, et al., 1978; Moore, et al., 1979). 
The method is too slow to be useful for kinetic studies, but 
does show the time dependent inactivation by agonists thought 
to be in vitro desensitization (Miller, et al., 1978). The 
amplitude of the flux is dependent on the agonist concentration 
(Bernhardt and Neumann, 1978; Miller, et al., 1978; Neubig, et 
al., 1979; Moore, et al., 1979). The flux is blocked by 
both a-BuTx and HTX, as expected from in vivo studies with these 
ligands. Elegant flux measurements of alkali treated membrane-
bound AcChR in which known fraction of the AcChR had been blocked 
by a-BuTx demonstrated that the four subunits contained in these 
membrane fragments and not some minor component are responsible 
for ion flux (Moore, et al., 1979). 
Improved technology has allowed measurement of in vitro 
ion flux on a time scale short enough to allow comparison with 
in vivo data. Thallium ion influx into vesicles loaded with a 
fluorescent molecule results in a quenching of the dye and 
allows observation of the agonist induced Tl+ flux with only a 
2.5 x 10-3 sec dead time in the stopped-flow spectrometer 
(Moore and Raftery, 1980). The single channel flux rate is 
comparable to the rate in vivo. Thus in vitro flux for prepara-
tions of defined protein composition has been demonstrated and 
the specific lipid composition necessary, if any, is the 
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remaining unknown. Modification of the lipid composition requires 
solubilization of the membrane fragments and here also a great 
deal of progress has been made. 
Early attempts at reconstituting solubilized AcChR had to 
make use of AcChR solubilized in non-ionic detergents and then 
purified by affinity chromatography. It is now known that the 
AcChR is sensitive to minute amounts of bound detergent and also 
has important sulfhydryl groups which affect activity, thus it 
is not surprising that early reports of success in reconstituting 
agonist induced ion flux in AcChR containing vesicles (Michaelson 
and Raftery, 1974) proved difficult to reproduce consistently 
(Karlin, et al., 1975; McNamee, et al., 1975). When membrane 
fragments containing AcChR were solubilized with sodium cholate 
and then reformed into vesicles without further purification, 
preparations consistently capable of ion flux could be produced 
(Hazelbauer and Changeux, 1974). Functional preparations could 
also be obtained by adding large amounts of exogenous lipids 
to cholate solubilized· membrane fragments (Epstein and Racker, 
1978). The advent of alkali treatment of membrane fragments 
allowed production of cholate extracts containing essentially 
pure AcChR and subsequent reconstitution of these extracts into 
functional vesicles (Wu and Raftery, 1979; Changeux, et al., 
1979; Wu and Raftery, 1980). These vesicles were sealed 
and capable of agonist induced ion flux which could be blocked 
by a-BuTx or HTX (Wu and Raftery, 1980). 
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It is now generally accepted that the AcChR of Torpedo 
is composed of three (Neubig, et al., 1979) or four subunits 
(Raftery, et al., 1979; Weill, et al., 1974; Raftery, et al., 
1975; Chang and Bock, 1977; Lindstrom, et al., 1978; Vandlen, 
et al., 1979; · Strader, et al., 
1980). The subunits are of molecular weights 40,000, 50,000, 
60,000 and 65,000 daltons and are present in a stoichiometry of 
2:1:1:1 (Strader, et al., 1980a). The locations of the various 
binding sites on these subunits are not completely known, nor 
is the composition of the ion channel. 
Bromoacetylcholine (Chang, et al., 1977; Damle, et al., 
1978; Moore and Raftery, 1979a) and 4-(N-maleimido)benzyltri-
methylammonium iodide (Weill, et al., 1974) were used to 
covalently label the AcCh binding site, which is known to possess 
a disulfide bond which can be reduced and labeled 
with sulfhydryl reagents like the above. The labeling experi-
ments found that the iabels were incorporated into the 40,000 
dalton subunit. Cholinergic analog photoaffinity reagents 
have been synthesized and used with some success. Bis(3-
azidopyridinium)-l,10-decane perchlorate labeled the 40,000 
and 50,000 dalton subunits of membrane-bound AcChR, while it 
labeled the 40,000 and 60,000 dalton subunits of Triton X-100 
solubilized AcChR purified by affinity chromatography 
(Witzemann and Raftery, 1977). Bis(azido)ethidium chloride 
labeled the 40,000 dalton component of AcChR enriched membrane 
fragments and this labeling was partially blocked by a-BuTx 
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(Witzemann and Raftery, 1978b). Incubation of the membrane 
fragments with agonist prior to labeling increased the amount 
of bis(Azido)ethidium incorporated into the 40,000 and also the 
50,000 and 65,000 dalton subunits. Solubilized AcChR was 
labeled using 4-azido-2-nitrobenzyltrimethylammonium fluorborate 
(Hucho, et al., 1978). While all four subunits incorporated 
label only the labeling of the 40,000 dalton subunits was 
prevented by preincubation with a-BuTx. The conclusion of 
these studies is that the 40,000 dalton subunit contains the 
agonist site and that either the other subunits are in such 
close proximity to this site that they are labeled by diffusion 
of the photoactivated analog from the site on the 40,000 dalton 
subunit or that there are secondary sites for the analogs on 
the other subunits. These secondary sites may have evolved 
from a single original site given the discovery that the four 
subunits are homologous (Raftery, et al., 1980). 
a-BuTx-azide has·also been synthesized and found to label 
the 40,000 and 65,000 dalton subunits (Witzemann, et al., 1979). 
This indicates that the 65,000 dalton subunit was exposed to 
the aqueous phase in addition to the 40,000, 50,000 and 60,000 
subunits as demonstrated earlier by lactoperoxidase catalyzed 
iodination (Hartig and Raftery, 1977). 
The local anesthetic analog procaine amide azide(PAA) was 
synthesized and labelled principally the 43,000 and 90,000 dalton 
proteins of Torpedo membrane fragments, with smaller amounts of 
label incorporated into the AcChR subunits (Blanchard and 
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Raftery, 1979). Alkali treatment of the membrane fragments 
removed the 43,000 dalton and most of the 90,000 dalton 
labeling allowing observation of PAA binding to the 40,000, 
60,000 and 65,000 dalton subunits (Blanchard, 1980). Carb 
preincubation protected the 40,000 dalton subunit from labeling 
so that the PAA binding observed on this subunit may have been 
due to binding of the analog to the agonist site. Non-specific 
binding and presence of substantial analog affinity at a site 
not biologically relevant to the analog are major problems 
with photo affinity reagents, especially those which are 
hydrophobic. 
Substantial interest was shown by the medical community 
(Check, 1978) in the finding that symptoms similar to 
myasthenia gravis could be induced in rats by injecting them 
with any of the four subunits of AcChR isolated from Torpedo 
(Lindstrom, et al., 1978). The conclusion that experimental 
autoimmune myasthenia gravis (EAMG) is caused by antibodies 
to the AcChR and subsequent degradation of those AcChR-
antibody complexes led to a substantial revision of thinking 
on the causes of myasthenia gravis in humans. 
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CHAPTER I 
Ligand Binding Studies Involving the HTX Binding Site of 
Membrane Bound Acetylcholine Receptor 
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INTRODUCTION 
The histrionicotoxins were first isolated from the South 
American "poison arrow" frog Dendrobates histrionicus (Daly, 
et al., 1971). The compounds are alkaloids which differ in 
the degree of saturation of their side chains but retain the 
same basic Az a.spiro structure. The natural poison extracted 
from the frog is composed chiefly of HTX and H2 -HTX (Daly, 
et al., 1971) and minor amounts of more saturated derivatives 
(Tokuyama, et al., 1974). The fully saturated derivative 
perhydrohistrionicotoxin, H12 -HTX is not found naturally but 
has been synthesized by catalytic reduction of natural HTX and 
by several routes of total synthesis (Aratani, et al., 1975; 
Fukuyama, et al., 1975; Corey, et al., 1975, 1977; Cherpeck, 
1980). H12 -HTX has been shown to have biological activity 
similar to HTX (Albuquerque, et al., 1973a). Histrionicotoxins 
are based on an eleven carbon Azaspiro ring which has several 
possible conformations. X-ray crystallography of the HCl salt 
of HTX indicates that the ring is in a chair conformation 
(Daly, et al., 1971), placing the hydroxyl group in close 
proximity to the amino group. With this conformation, the 
molecule is approximately an oblate ellipsoid, with the two 
hydrophilic groups oriented in one face, leaving the opposite 
face completely hydrophobic. The ring conformation does not 
seem dependent on the degree of chain saturation (Daly, et al., 
1971; Karle, 1973). The conformation has interesting implica-
tions for the structure of the HTX binding site. 
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Perhydrohistrionicotoxin (Fig. 1, I ) is a small molecule 
which non-competitively blocks the acetylcholine induced 
depolarization of the postsynapic membrane (Albuquerque, et al., 
1973a, 1973b). It has been shown that this block is caused 
by specific interaction of the toxin molecule with the acetyl-
choline receptor (Albuquerque, 1973a, 1973b; Eldefrawi, et al., 
1975; Elliott, et al., 1979), possibly by interacting with the 
ion channel, although an alternative hypothesis (Kato and 
Changeux, 1976) is that HTX greatly accentuates the process of 
densitization in a manner similar to that proposed for local 
anesthetics (Magazanik and Vyskocil, 1973). Because this 
molecule is one of the few which may interact with the ion 
channel of the AcChR, it has been the subject of intensive 
investigation (Ka to, et al. , 1974; Albuquerque, et al., 1974; Elliott 
and Raftery, 1979; 
1979). 
Eldefrawi, et al., 1977; Neubig, et al., 
3H-H 12 -HTX binds· to the membrane bound AcChR present in 
Torpedo electroplax with a Kd of 0.3 to 0.5 µM (Elliott and 
Raftery, 1977). The Kd of [ 3H]-H 12 -HTX decreases about two-
fold when the AcChR is incubated with 10 µM Carb prior to the 
HTX binding assay (Elliott and Raftery, 1979), which may reflect 
a conformational change in the AcChR related to desensitization. 
Detergent solubilization of the AcChR enriched membranes 
destroys the ability of the AcChR to bind HTX (Elliott and 
Raftery, 1977, 1979). This fact, along with the effects of 
low concentrations of amphipathetic molecules on [ 3H]-H 12 -HTX 
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binding (Elliott, et al., in press), may indicate that the 
membrane itself constitutes a vital part of the structure of 
the HTX binding site. Positively charged amphiphiles such as 
local anesthetics, compete quite strongly with [3H]-H 12 -HTX 
for its binding site on the AcChR (Blanchard, et al., 1979b) while 
neutral amphiphiles are much less effective (Elliott, et al., 
submitted). Octylguanidine, known to block frog endplate 
depolarization (Narahashi, 1980) has been found to be particularly 
effective in competing with [ 3H]-H 12 -HTX with an apparent Kd 
of 1.5 µM. Methylguanidine also blocks endplate depolarization, 
albeit more weakly than octylguanidine (Narahashi, 1980) and 
has also been shown to compete with [ 3H]-H 12 -HTX with a Kd 
of 50 rnM. The large difference in effectiveness between octyl 
and methyl guanidines suggested that the hydrophobic elements of 
the ligand might be important determinants of binding affinity. 
A series of experiments has been done to determine the binding 
properties of alkylguanidines to AcChR enriched membrane 
fragments in an effort to establish a clear relation between 
hydrophobicity and ligand binding. 
I have also investigated the binding properties of several 
derivatives of HTX. Results of these experiments, together 
with the alkylguanidine data, lead me to propose a model for 
binding in which the membrane lipids form the hydrophobic 
domain of the AcChR HTX binding site. 
An azide analog of HTX was the generous gift of 
Dr. R. Cherpeck and Professor D. Evans. This analog 
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was tritiated and shown to bind to the HTX site of the AcChR 
with high affinity. Upon photolysis the analog was incorporated 
into the 40K , 50K and 65K subunits of the AcChR, though 
only that binding to the 65 K dalton subunit could be completely 
blocked by competition with H8 -HTX. 
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MATERIALS AND METHODS 
I. General 
H12 -HTX and Ift3-HTX were the gifts of Professor Y. Kishi. 
[ 3H]-H 12 -HTX was produced by tritiation H8 -HTX which was 
performed by ICN Pharmaceuticals, Inc. (Irvine, California). 
Purification and standardization of the [ 3H]-H 12 -HTX have been 
described (J. Elliott, 1979). HTX-OH, HTX-amide and dehydroxy-
HTX were gifts from Dr. R. Cherpeck and Professor D. Evans. 
Crude Bungarus multicintus venom was obtained from Sigma 
Chemical Co. This venom was purified via ion exchange chroma-
tography (Clark, et al., 1972). The a-BuTx component of the 
venom was then iodinated using Na[ 125 I]. The monoiodo deriv-
ative was isolated and standardized (Blanchard, et al., 1979a). 
The [ 125 I]-a-BuTx had biological activity indistinguishable 
from the unlabeled a-BuTx and had specific activities that 
ranged from 1-3 Ci/mm~le. 
Octanol and alkylamines were obtained from Aldrich 
Chemical Co., methylguanidine was obtained from Sigma Chemical 
Co. Octylguanidine was the gift of Professor Narahashi. 
DE-81 DEAE filter paper discs were obtained from Whatman, 
Ltd. Scintillation counting was done using a Packard Tricarb 
Liquid Scintillation Spectrometer or a Beckman LS-233 Liquid 
Scintillation Spectrometer using Aquasol (New England Nuclear) 
on 25% v/v Triton X-100, 0.55% Permablend III (Packard) in 
Toluene. Glass scintillation vials (Wheaton) with sealing 
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caps were necessary for experiments in which SDS Polyacrylamide 
gel slices were digested in the vials. 
Protein concentrations were determined using the method 
of Lowry, et al. (1951). 
The concentration of [1 25 1]-uBuTX binding sites in the 
various preparations was assayed using the DEAE disc assay of 
Schmidt and Raftery (1972). 
Fluorescence spectroscopy was done using a Perkin-Elmer 
MPF-4 fluorometer. All NMR spectra were recorded with a Varian 
EM-390 NMR spectrometer. 
II. AcChR Enriched Membrane Fragments 
Approximately 500g of frozen electric organs from T. 
californica were broken into small pieces and mixed with 500 mL 
of buffer [10 mM NaPi, 5 mM EDTA, 0.02% NaN 3 , 5 rnM iodoacetamide, 
10 mM PMSF pH= 7.4]. This was ground for 2 minutes in a 
Waring Blendor, then reground for 4 x 30 seconds at 30,000 rpm 
in a Virtis 60 homogenizer. Large particles and connective 
tissue were removed by a 10 minute centrifugation at 5000 rpm 
in a Sorval GSA rotor. The supernatant was then centrifuged 
60 minutes at 30,000 rpm in a Beckman 35 rotor. The pellet was 
resuspended in 10 mM NaPi (pH 7.4) 1 rnM EDTA by using 2 x 30 -
second homogenizations with a Virtis 60 homogenizer. Sucrose 
and NaCl were added to achieve final concentrations of 30% (w/w) 
and 0.4 M, respectively. 
The sample (10 ml) was layered on a discontinuous sucrose 
gradient with steps of 5 ml 50% w/w, 5 ml 39% w/w, and 12 ml of 
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30% w/w, all in 0.4 m NaCl, 10 mM Pi (pH= 7.4) 1 rnM EDTA. This 
buffer was used to adjust the final volume of each tube. 
The loaded tubes were centrifuged for 60 minutes at 
45,000 rpm in a VTi 50 rotor using a slow acceleration accessory 
and Beckman L-5B centrifuge. After centrifugation the membrane 
fragments were observed to be in three bands. The middle band, 
consisting of particles with a density of 1.18 g/cc, was aspir-
ated away from the gradients, diluted with buffer and 
centrifuged for 60 min at 35,000 rpm in a Beckman 35 rotor. 
The membranes were resuspended in a small amount (~lo ml) of 
Torpedo Ringers buffer using a Virtis homogenizer. This prepara-
tion is described in detail in Elliott, et al. (1980). 
III. Alkali Treatment of AcChR Enriched Membrane Fragments 
Alkali treatment of the membrane fragments from the above 
procedure was adapted from the protocol reported by Steck and Yu 
(1973) for erythrocyte ghosts. Membrane fragments containing 
approximately 50 mg of total protein were pelleted, resuspended 
in distilled water with a Virtis homogenizer and pelleted again. 
They were then resuspended in 80 ml of cold distilled water using 
a Virtis homogenizer for 2 x 30 sec. The suspension was 
then adjusted to pH 11.0 using 0.5% NaOH. This pH was maintained 
for 30 minutes at 4°, with small additions of NaOH. The membranes 
were then pelleted by centrifugation for 30 minutes at 30,000 
rpm in a Beckman type 35 rotor. A Virtis homogenizer was used to 
resuspend the pellet in Torpedo Ringer 1 s buffer. 
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IV. Synthesis of Alkyguanidin~s 
Alkylguanidines were synthesized by reacting S-ethylthiourea 
with the appropriate alkylamine, according to the procedures of 
Brand and Brand (1942) as follows: 
A. s~ethylthiour~a Hydrob~o~ide. Fifteen grams of 
thiourea were mixed with twenty-five grams of ethyl bromide 
dissolved in 20 ml of dry ethanol. The mixture was refluxed 
overnight. The solvent was removed using a rotary evaporator 
and the resulting oil was allowed to crystallize overnight at 
-20°. The crystals were removed by filtration and subsequently 
washed with ethanol and dried. The yield was 34 g, which was 
94% of the theoretical yield. 
B. Alkylguanidines. The desired alkylguanidine deriv-
ative may be prepared by reacting S-ethylthiourea with an 
alkylamine having a side chain of the desired length; (NH2)2C 
SC2Hs) + R-NH 2 ~ (NH 2 ) 2 '-C-NH-R + C2H5 SH. This reaction was 
accomplished by dissolving .05 moles of alkylamine in either 
25 ml of cold 2.0 N NaOH or, in the case of alkylamines with 
side chains longer than 4 carbon atoms, a mixture of 80% tetra-
hydrofuran and 20% 10.0 N NaOH. Solid S-ethylthiourea (.05 moles) 
was slowly added to this mixture with constant stirring. The 
reactants were stirred at room temperature overnight inside a 
fume hood. The solvent was then removed with a rotary evaporator 
and the remaining solid, which is a mixture of NaBr, product, 
unreacted starting material and small amounts of urea, was 
triturated with n-butanol. The butanol was decanted away from 
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the remaining solids and neutralized using ethanol saturated 
with HCl gas. The HCl salt of the R-guanidine was then recovered 
by evaporation. Recrystallization could usually be achieved 
from butanol. Yields were typically about 50% of the theoretical 
maximum. 
C. Dansylguanidine (Fig. l; VII). Dansylguanidine was 
synthesized in three steps. First, cystamine was reacted with 
S-ethylthiourea to form 1,4 bis(guanido) cystamine using the 
protocol above. This product was dissolved in water and reduced 
with a two-fold excess of sodium borohydride to yield 2-guanido 
ethanethiol. Forty mg (330 µ moles) of 2-guanidoethanethiol was 
dissolved in 20 ml of 0.1 M carbonate buffer (pH 8.3) and was 
mixed with 80 mg (290 µ moles) of Dansylaziridine (Molecular 
Probes, Inc.), dissolved in 10 ml of ethanol. This mixture 
was refluxed for 12 hours, cooled and evaporated to dryness 
using a rotary evaporator. The product was purified as described 
in part B of this section. The yield was about 10%. The low yield 
was due mainly to high handling losses of the small amount of material. 
V. Synthesis of HTX-H (Fig. 1, III) 
Synthesis of HTX-H was accomplished by reduction of HTX-
amide (Fig. 1, IV) with lithium aluminum hydride. A 100 ml round 
bottom flask and small refluxing condenser were ' assembled, purged 
and slightly pressurized with dry argon. Into this apparatus 
was introduced 19 mg (500 µ moles) of lithium aluminum hydride 
dissolved in 5 ml of anhydrous diethyl ether. Then 26.2 mg (107 
µ moles) of HTX-amide was dissolved in 5 ml of dry diethylether 
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Figure 1. Histrionicotoxin derivatives. Chemical names for 
derivatives in these experiments may be found in the 
abbreviations section. 
I) H12 -HTX 










][ H H 
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and this was slowly added to the contents of the flask. The 
reactants were refluxed under dry argon for 8 hours. 
The mixture was then cooled in an ice bath and a large 
excess of Na 2 S0 4 • 10 H2 0 was slowly added. The Na 2 S0 4 was 
then filtered away from the reaction mixture and the ether 
phase evaporated to dryness. Thin layer chromatography on a 
silica gel plate eluted with chloroform:isopropanol:aqueous 
ammonium hydroxide (9:2:0.16) showed only one component when 
stained with iodine. The NMR spectrum was consistent with a 
compound of structure III in Fig. 1. 
VI. Determination of Ligand Binding Constants 
Inhibition constants of the various ligands were determined 
by competition with HTX or with Carb. Membrane fragments were 
mixed with [ 3H]-H 12 -HTX or [ 3H]-Carb and titrated with the ligand 
of interest. The mixture was allowed 30 minutes to equilbrate 
and then the membranes were pelleted using a Beckman Airfuge. 
The concentration of [ 3H]-H 12 -HTX or [
3H]-Carb remaining in the 
supernatant was measured and from this value the fraction of 
[3H]-H 12 -HTX or [3H]-Carb bound to the membrane fragments at a 
given titrant concentration was determined. The amount of 
non-specific binding to the membrane was determined by saturation 
of specific sites with H8 -HTX before centrifugation. The centri-
fugation assay for HTX binding was originally described by 
Elliott and Raftery (1977). Using the known values for the 
dissociation constants of [ 3H]-H 12 -HTX and [ 3H]-Carb allowed 
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correction of the ligand inhibition constants into dissociation 
constants. 
All assays were performed in Torpedo Ringers (250 mM 
NaCl, 5 mM KCl, 4 mM CaC1 2 , 2 mM MgC1 2 , buffered to pH 7.4 by 
20 mM Hepes) except for the assays of HTX binding versus pH. 
In these assays the divalent ions were omitted and the pH 
was maintained by 50 mM sodium citrate for assays between 
pH 3 and 6.5, 50 mM sodium phosphate for pH values between 
7 and 7.5, 50 mM sodium pyrophosphate for pH values between 
8 and 9, 50 mM sodium carbonate for pH 9.5 and pH 10, and 
50 mM sodium phosphate (tribasic) for pH values above 10. 
The sodium concentration was maintained at a constant 150 mM 
by addition of 1 M NaCl. 
VII. Determination of Alkylguanidine Partition Coefficients 
The relative partition coefficients of long chain alkyl-
guanidines between the membrane fragments and Torpedo Ringers 
buff er were determined using a fluorimetric assay based on the 
reaction of ninhydrin with guanidine derivatives to give a 
fluorescent product (Conn and Davis, 1959). 
Membrane fragments were mixed with the alkylguanidine 
derivative in question to a final ligand concentration of 10- 4 M. 
The conditions were chosen so that the assay mixtures were about 
2 mM in phospholipid concentration and 2 µM in a-BuTx site 
concentration. Aftera30 minute equilibration period, the 
membrane fragments were pelleted by centrifugation and the 
supernatant was assayed for alkylguanidine concentration as 
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follows: 1 ml of 0.5% aqueous ninhydrin was added to 0.9 ml of 
water and 0.1 ml of the supernatant sample. The solution was then 
mixed and 1 ml of 1.0 N KOH was added. After a 15 min incubation 
the fluorescence of 495 nm was measured using an excitation 
wavelength of 390 nm. A standard curve for the alkylguanidine 
being assayed was determined simultaneously. The ratio of the 
supernatant ligand concentration to the starting concentration 
was taken as the partition coefficient. The method was not useful 
for short chain (2 4 carbon atoms) alkylguanidines, as the 
difference between the starting mixture and supernatant was small. 
VIII. AcChR Subunit Labeling with HTX-N3 
1H2 -HTX-N 3 (Fig. 1, compd. VIII) was synthesized by Dr. R. 
Cherpeck (1980) by reacting 4-fluoro,2-nitrophenylazide with 
HTX-OH (Fig. I, compd. II). This material was tritiated using 
the Wilzbach method by ICN Pharmaceuticals Inc. (Irvine, Califor-
nia). The crude [3H]-~TX-N 3 (Fig. 1, cmpd. VIII) was purified 
on a 5 x 100 mm silica gel column eluted with 9:2:0.16 chloroform: 
isopropanol:aqueous ammonium hydroxide. This and all subsequent 
purification and assay manipulations were done using only the 
light from a 25 W red light bulb. A fraction was obtained in 
which the radioactivity comigrated with 1H2 -HTX-N 3 that was used 
as a standard. This fraction was evaporated to dryness and a 
small amount was weighed and dissolved in ethanol. The specific 
activity was 0.3 Ci/mrnole. 
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The binding affinity of [ 1 H]-HTX-N 3 to AcChR enriched 
membrane fragments was determined by competition with [ 3H]-HTX 
using the centrifugation assay described above, while the affinity 
of the [3H]-HTX-N 3 was measured directly by the centrifugation 
assay. 
The membrane fragments were incubated in the dark for 30 
minutes with [ 3H]-HTX-N 3 at the desired concentration, then 
placed in a cylindrical quartz cuvette and irradiated 15 minutes 
with stirring. The light source was a UVSL-25 lamp (Ultraviolet 
Products , San Gabriel, California) set to the 1 'long" wave-
length. The membrane fragments were then pelleted by a 5 
minute centrifugation with an Eppendorf 3200 centrifuge. The 
pellet was resuspended in Torpedo Ringers and pelleted once 
again. This pellet was dissolved in SDS sample buffer (20% 
sucrose w/w, 3% w/v SDS, 62.5 mM Tris pH 6.8, 50 mM DTT and 
0.1% bromophenol blue). 
The sample was applied to a 1 x 10 cm SDS polyacrylamide 
gel (8.75% acrylamide) and electrophoresed using the method 
of Laemmli (1970). The gels were subsequently sliced without 
staining with a Hoeffer Scientific Instruments SL-280 gel slicer. 
Each slice was placed in a glass scintillation vial (Wheaton Co.) 
and 0.5 ml of 30% hydrogen peroxide was added. After tightly 
capping the vials, the samples were incubated six hours at 70°C. 
The vials were then cooled and 10 ml of scintillation fluid were 
added . The radioactivity present in the vials was determined 
using a Beckman LS-233 liquid scintillation spectrometer. 
47 
RESULTS 
I. Ligand binding to the HTX site 
Alkylguanidines with chain lengths from one to eight carbons 
were found to compete with the binding of f 3H]-H 12 -HTX to the 
AcChR enriched membrane fragments (Table I). The titrations all 
resulted in normal Bjerrum-type sigmoidal curves (Figs. 2- 4). 
In addition the amount of non-specific [ 3H]-H 1 z-HTX binding 
remained constant throughout the range of the titration, regard-
less of the chain length of the titrant (Figs. 2 - 4). The 
inhibition constants of the alkylguanidine derivatives were 
strongly dependent on the alkyl chain length with the longer 
chains inhibiting more strongly (Table I). The Kds changed by 
over 4 orders of magnitude in the range of linear side chains 
tested. Non-linear alkylguanidines also exhibited specific 
competition with [ 3H]-H 12 -HTX (Fig. 2) with Kds dependent on the 
hydrophobicity rather than the total chain length (Table I). Other 
amphiphiles, such as octylamine and octanol, were tested for 
their ability to compete with [ 3H]-H 12 -HTX; octylamine did 
compete, although with an affinity more than two orders of magni-
tude weaker than octylguanidine (Table I). Octanol had no 
effect on [ 3H]-H 12 -HTX binding at concentration up to 0.3 nM, 
which was the practical limit of the titration due to the 
limited solubility of the titrant. 
The plot of log Kd vs chain length (Fig. 5) of the alkyl-
guanidines suggested that the partition coefficient of the ligand 
was a critical factor in determining its affinity for the AcChR 
HTX binding site. The relative partition coefficients between 
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Table I. Alkylguanidine Dissociation Constants Determined by 




















5.0 x 10- 2 
4.5 x 10-2 
1. 5 x 10- 2 
1.0 x 10-
2 
1. 8 x 10- 3 
1. 9 x 10- 3 
4.0 x 10- 4 
1. 9 x 10- 3 
8.0 x 10- 5 
1. 5 x 10- 6 
2.7 x 10- 5 
>> 3 x 10-
4 
- 4 
5 x 10 
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Table II. Dissociation Constants of Alkylguanidines Determined 




1.5 x 10- 3M 
3 x 10- 3M 
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Table III. Dissociation Constants of HTX Derivatives Determined 
by Competition with [ 3E]-H 12 -HTX 
HTX-H 1. 2 x io- 5M 
HTX-OH 1. 5 x io- 5M 
2R-Dehydroxy-HTX 1.4 x l0- 6M 
2S-Dehydroxy-HTX 1.1 x io- 6M 
HTX-N 3 1 5 x 10- 6M 
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Figure 2. The competition of methylguanidine with [ 3H]-H 12 -HTX 
binding. AcChR enriched membrane fragments (1.5 µM in 
a-BuTx sites) were titrated with methylguanidine. The 
membrane fragments were suspended in Torpedo Ringers buffer 
with 0.5 µM [ 3H]-H 12 -HTX (•-•-•) or 0.5 µM [ 3H]-H 12 -HTX + 
44 µM H8 -HTX (!-!-!). After 30 minutes of incubation at 
room temperature, the membrane fragments were pelleted and 
the amound of radioactivity remaining in the supernatant 
was determined. 
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Figure 3. The competition of n-Pentylguanidine with [3H]-
H12-HTX binding. AcChR enriched membrant fragments 
(1.5 µm in a-BuTx sites) were titrated with n-pentyl-
guanidine. The membrane fragments were suspended in 
Torpedo Ringer's buffer with 0.5 µM [ 3H]-H 12 -HTX 
(•-•-•) or 0.5 µM [ 3H]-H 12 -HTX plus 44 µM H8 -HTX 
(!-!-!). After 30 minutes of incubation at room 
temperature, the membrane fragments were pelleted and 
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Figure 4. The competition of n-Heptylguanidine with [3H]-H 12 -
HTX binding. AcChR enriched membrane fragments (1.5 µM 
in a-BuTx sites) were titrated with n-heptylguanidine. 
The membrane fragments were suspended in Torpedo Ringer's 
buffer with 0.5 µM [ 3H]-H 12 -HTX (•-•-•)or 0.5 µM 
[ 3H]-H 12 -HTX plus 44 µM H8 -HTX (A-A-A). After 30 minutes 
of incubation at room temperature, the membrane fragments 
were pelleted and the amount of radioactivity remaining 






































Figure 5. A plot of log Kd versus chain length of linear 
alkylguanidines. The log of the Kd of the linear chain 
alkylguanidines was plotted against the number of carbon 
atoms in their sidechains. The two linear portions of 
the plot have slopes of -900 cal/carbon atom and -2400 
cal/carbon atom. The Kds of neopentylguanidine, cyclo-
hexylguanidine and octylamine are shown on the line for 
illustration purposes; they were not used in calculating 
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Figure 6. The competition of neopentylguanidine with [3H]-
H12-HTX binding. AcChR enriched membrane fragments 
(1.5 µM in a-BuTx sites) were titrated with neopentyl-
guanidine. The membrane fragments were suspended in 
Torpedo Ringer's buffer with 0.5 µM [ 3H]-H 12 -HTX 
(•-•-•) or 0.5 µM [ 3H]-H 12 -HTX plus 44 µM H8 -HTX 
(A-A-A). After 30 minutes of incubation at room 
temperature, the membrane fragments were pelleted and 
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Figure 7. A plot of log Kd versus relative partition 
coefficient of some alkylguanidines. The membrane 
fragments (~2 mM lipid, 2 µM a-BuTx sites) were incu-
bated 30 minutes with the alkylguanidine (10- 4 M) of 
interest, then pelleted. The concentration of alkyl-
guanidine remaining in the supernatant was divided by 
the concentration before pelleting to give the relative 
partition coefficient. The value is not the true 
partition coefficient, as the exact concentration of 
lipid accessible to the alkylguanidine was not known. 
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buffer and membrane fragments were determined and it was found 
that a plot of log Kd vs. relative partition coefficient was 
a straight line, even with inclusion of cyclohexylguanidine 
Fig. 7). The absolute partition coefficients could not be 
determined because of the uncertainty as to what concentration of 
membrane lipid was truly accessible to the amphipathic ligands. 
Studies with alkylguanidines were also undertaken in which 
these cc:.mpounds were competed with [ 3H] -Carb (Fig. 8) . It 
was found that these ligands exhibited a moderate affinity for 
the AcChR agonist binding site. No chain length dependence 
was observed in the range tested (one th~ough five carbon atoms) 
(Table II). A previous study using spin-labeled acylcholines 
(Bienvenue, et al., 1977) reported that there was a correlation 
between hydrophobicity and ligand affinity. However, the 
acylcholines used had very long (16 or 18 carbon atoms) side 
chains. It is possible that only the distal ends of these 
side chains were partitioning into the membranes. 
The binding properties of the HTX derivatives examined in 
this study are informative as to the structure of the binding 
site. Perhydrohistrionicotoxin has a structure in which the 
number two position of azaspiro undecane system is substituted 
with a pentyl group (Fig. 1, I). Binding studies in which 
compounds II, III (Fig. 9) and both stereoisomers of V were 
competed with [3HJ-H 12 -HTX demonstrated (Table III) that the 
stereochemistry of the 2-position substituent did not affect 
the affinity of the ligand. Omission of the pentyl group from 
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Figure 8. The competition of n-pentylguanidine with Carb 
binding. AcChR enriched membrane fragments (0.6 µM in 
a-BuTx sites) were titrated with n-Propylguanidine. The 
membrane fragments were suspended in Torpedo Ringer's 
with 0.14 µM [3H]~Carb. After 30 minutes incubation at 
room temperature, the membrane fragments were pelleted 
and the amount of radioactivity remaining in the super-
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Figure 9. The competition of HTX-H with [ 3H]-H 12 -HTX 
binding. AcChR enriched membrane fragments were titrated 
with HTX-H. The membranes (1.5 µM in a-BuTx sites) were 
suspended in Torpedo Ringer's with 0.5 µM [ 3H]-H 12 -HTX 
(•-•-•)or 0.5 µM [ 3H]-H12-HTX + 44 µM Hs-HTX (!-!-!). 
After 30 minutes in incubation at room temperature, the 
membrane fragments were pelleted and the amount of 
radioactivity remaining in the supernatant was determined. 
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the toxin structure or modification of the group into a structure 
with a terminal hydroxyl group substantially affected the binding 
constant. The affinities of compounds II and III were more than 
thirty-fold lower than the affinity of H12 -HTX (Table II), 
corresponding to a loss of ~G of 2.1 kcal/mole when calculated 
by using the formula G = -RT ln K eq 
Binding assays with compound V, dehydroxy-HTX, showed that 
its affinity was surprisingly high; being only 3-fold lower 
than H12 -HTX (Table III). This result was quite unexpected as 
this derivative is missing the hydroxyl group at the number 8 
position which was presumed to be vital for HTX binding. It 
should be noted, however, that this derivative is much more 
hydrophobic than H12 -HTX and, as will be discussed, hydropho-
bicity appears to be a vital parameter in determining a ligand's 
affinity for the HTX site. 
II. pH Dependence of . HTX Binding 
Figure 10 demonstrates the pH dependence of [ 3HJ-H 12 -HTX 
binding (from Elliott, et al., 1980). It is apparent that 
the midpoint of the high pH decrease in binding is 10.1. The 
shape of this plot is consistent with the ionization of a single 
group and the value of pK determined is consistent with that 
a 
of an amino group, probably that of HTX itself. The loss of 
binding activity at low pH is very rapid and is probably due to 
an effect on more than one group and/or to denaturation of the 
AcChR. It was hoped that a study correlating Kd vs. pH would allow 
determination of the pK of the AcChR group responsible for HTX a 
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Figure 10. [3H]-H 12 -HTX binding versus pH. AcChR enriched 
membrane fragments (1.2 µM in a-BuTx binding sites) 
suspended in buffers of various pHs but constant Na+ 
content were mixed with 0.3 µM [ 3H]-H 12 -HTX. After 20' 
incubation the membrane fragments were pelleted and the 
amount of radioactivity in the supernatant assayed. A 
parallel experiment was done in which 40 µM H8 -HTX was 
added to the samples to saturate all specific HTX binding. 
Specific [3H]-H 12 -HTX binding was then calculated and 






















binding. A slight (2x) weakening of binding was observed as 
pH was decreased to 6.0, with the decrease beginning at 6.5. 
Unfortunately, below pH 6.0 a loss of binding sites was observed 
(Fig. 11) and the data vital to the pK determination were 
a 
unobtainable. We can state only that the pKa of the group is 
less than 6.5. 
III. The Binding of Dansylguanidine (Fig. l; VII) 
Dansylguanidine was synthesized in the hope that it would 
serve as a fluorescent probe of the HTX site suitable for use 
in stopped-flow spectroscopy. As it is quite hydrophobic a 
high binding affinity was predicted and this was found to be 
the case; the Kd was 27 µM when assayed using competition with 
[3H]-H12-HTX. 
A very large (~100 X) increase in fluorescence accompanied 
by a blue shift of ~30 nm in the amines on moderation was 
found when the ligand was mixed with AcChR enriched membrane 
fragments. When Hs-HTX was added in large excess, the fluor-
escence intensity was decreased only slightly (~10%). 
Attempts at using the ligand as a probe in the stopped-flow 
spectrometer failed, however. At least four phases were 
-1 -1 apparent, with rates which ranged from 150 s to 0.03 s . 
These phases were not altered upon addition of octylguanidine 
and it was thought that all were related to partitioning of 




[ 3H]-H 12 -HTX binding titrations at pH 7.5 and 
a) AcChR enriched membrane fragments (1.4 µM in a-BuTx 
binding sites) were suspended in pH 7.5 buffer. [3H]-
H12-HTX was added in increasing concentration to each 
successive aliquot and allowed to incubate 20' minutes 
at room temperature. The membrane fragments were then 
pelleted and the radioactivity remaining in the super-
natant was determined. A parallel titration was done in 
in which 40 µM H8 -HTX was added to the aliquots to 
saturate all specific HTX binding. 
b) The same experiment as in A, except that pH 5.3 
buffer was used. The concentration of AcChR is 
identical to that in Section a. 
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apparently obscured any signal due to specific binding of ligand 
to the AcChR site responsible for HTX binding. 
IV. Labeling of the AcChR with [ 3H] -H 12 -HTX-N 3 (Fig. 1, VI I I) 
As is shown in Fig. 11, [ 3H]-HTX-N 3 labeled three of the 
four protein subunits present in the alkali treated membranes. 
Proteins of molecular weight 40,000, 50,000, and 65,000 daltons 
were labeled in ratios of approximately 4:1:1 respectively, 
when labeled with 6 µM [ 3H]-HTX-N 3 • This concentration of 
HTX-N 3 is approximately twice the Kd (Figure 15). 
Higher proportions of the 40,000 dalton protein were labeled 
as the concentration of HTX-N 3 was increased. When H8 -HTX was 
added in large excess (Fig. 14), all labeling of the 65,000 dalton 
protein was blocked, while the labeling of the 40,000 and 50,000 
dalton proteins was only partially blocked. The residual 
labeling in both these subunits decreased by proportionally the 
same amount. Preincubation with Carb did not alter the labeling 
significantly (Fig. 13). Preparations which contained the 
90,000 dalton and 43,000 dalton subunits showed large amounts 
of label incorporation into the 90,000 dalton protein. Labeling 
experiments with this and other hydrophobic photoaffinity 
labels (Blanchard and Raftery, 1979) have been plagued with large 
amounts of what is presumably non-specific binding which makes 
careful control of the labeling conditions critical. 
It should be noted that in a typical experiment, 95% of the 
label initially mixed with the membrane fragments was removed 
in the two washing steps prior to application to the gel. This 
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was presumably unbound ligand and ligand which reacted with 
water after photolysis. Of the remaining 5%, 98% was found 
ahead of the dye front, which is the position in which phos-
pholipids electrophorese on SDS gels. This left 0.1% of the 
total label used actually bound to protein. 
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Figure 12. Labeling of alkali treated AcChR enriched 
membrane fragments with HTX-N 3 . AcChR enriched membrane 
fragments were treated with alkali such that their final 
specific activity was 3.2 mmoles of a-BuTx sites per mg 
of protein. These membranes were then mixed in the dark 
-4 3 with 7.8 x 10 M [ H]-HTX-N 3 and Torpedo Ringer's buffer 
to give final concentrations of 1.9 µM a-BuTx sites and 
5.6 µM [3H]-HTX-N 3 . After 30 minutes of incubation in 
the dark, the mixture was transferred into a 2 ml cylin-
drical quartz curvette with a small stirring bar inside. 
This was then irradiated 15 minutes with a UVSL-25 
ultraviolet light (Ultraviolet Products Co., San Gabriel, 
California). The membranes were pelleted and resuspended 
twice with changes of buffer each time. 
Then membrane fragments corresponding to 0.6 mg of 
total protein were loaded onto a 1 x 10 cm SDS-polyacryl-
amide gel and electrophoresed. The gel was then sliced, 
digested and counted. 
The positions of the 65, 60, 50, and 40 x 103 dalton 
subunits are shown based on Rf values determined with a 
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Figure 13. The effect of Carb on the labeling of alkali 
treated AcChR enriched membrane fragments with HTX-N 3 . 
The same protocol as described in the caption to Fig. 12 
was used, except that the membrane fragments were 
incubated with 1 µM Carb 5 minutes prior to addition 
of [3H]-HTX-N 3 . The membrane fragment preparation used 
was the same as that used in the experiments described 























Figure 14. Labeling of alkali treated membrane fragments 
with [3H]-HTX-N 3 in the presence of H8 -HTX. The same 
protocol as described in the caption of Fig. 12 was 
followed, except that 100 µM H8 was also included in 
the membrane fragment and [ 3H]-HTX-N 3 mixture. The 
same membrane fragment preparation was used as in the 
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Figure 15. The competition of HTX-N 3 with [ 3H]-H 12 -HTX 
binding. AcChR enriched membrane fragments were titrated 
with HTX-N 3 • The membrane fragments (1.4 µMin a-BuTx 
sites) were suspended in Torpedo Ringer's buffer with 
either 0.5 µM [ 3H]-H 12 -HTX (•-•-•)or 0.5 µM [ 3H]-H 12 -HTX 
plus 44 µM H8 -HTX (!-!-!). After a 30 minute incubation, 
the membrane fragments were pelleted, and the amount of -




































The above results (Fig. 10) have indicated that HTX must 
be ionized in order to bind to the AcChR. Further evidence 
of this is that octylamine competes with [3H]-H 12 -HTX for 
the AcChR site, whereas octanol, with a headgroup capable 
only of forming a hydrogen bond, competes weakly, if at all, 
even though long chain alcohols are known to act as anesthetics 
(Seeman, 1975). Octylguanidine, possessing both a charged 
group and a possible donor group for hydrogen bonding, binds 
much more tightly than octylamine, as would be expected if the 
AcChR site had two functional groups responsible for HTX binding. 
The difference in affinities corresponds to a difference in 
binding energies of 3.5 kcal/mole, which is consistent with the 
loss of a hydrogen bond. 
Among the several possible conformations for HTX, the one 
in which the azaspiro .ring is in the chair conformation uniquely 
allows superposition of the charged HTX amino group and the 
hydroxyl group, which is capable of forming a hydrogen bond to 
a suitable acceptor group, with two analogous groups of guanidine 
(i.e., the two nitrogens of a resonance form). A possible 
counter group for binding such a moiety would be a carboxylate 
ion, which meets steric requirements and possesses suitable charged 
and H-bond forming atoms. The chair conformation also results 
in an HTX molecule which is hydrophobic on one side and hydro-
philic on the other. The hydrophobic portion of the alkylguan-
idine molecule can be superimposed with portions of the 
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hydrophobic regions of HTX and still allow superposition of the 
hydrophilic groups. 
The more hydrophobic alkylguanidines inhibited HTX binding 
better than those with short alkyl chains (Fig. 5). The plot 
of log Kd vs. chain length has characteristics expected of a plot 
of partition coefficient vs. chain length. Short chain alkyl-
guanidines, in which the alkyl chain was within the hydration 
sphere of the headgroup, showed only a slight chain length 
dependence. Increasing the length gave linear dependence of log 
Kd vs. length until heptylguanidine. The slope of this linear 
region is about -900 calories per carbon atom, in excellent 
agreement with the -884 calories per carbon atom expected for trans-
fer of an aliphatic chain from water to a hydrocarbon (McAuliffe, 
1966; Tanford, 1973). The change in slope beyond this point is 
not typical of a hydrocarbon:water partition coefficient depend-
ence. This may be due .to a property of the membrane, which only 
approximates a hydrocarbon solvent. It is unlikely to be due to 
micelle formation because of the low concentrations involved 
(Reed and Trzos, 1979) and also the constant amount of non-
specific [ 3H]-H 12 -HTX binding throughout the titration, which 
suggests that the integrity of the membranes has not been 
disrupted. 
The discontinuity in Fig. 5 at the higher alkylchain lengths 
is removed if the partition coefficents measured experimentally 
are used in place of simple chain lengths (Fig. 7). This 
dependence of Kd upon what is a membrane:ligand interaction 
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implies that the membrane plays a key role in the binding of 
alkylguanidines to the AcChR. This could be explained if the 
hydrophobic ligands partitioned into the membrane prior to 
binding (Fig. 16). This partitioning would serve to create an 
enriched phase from which the ligand would bind to the receptor. 
Derivatives such as methylguanidine would probably bind only from 
the aqueous phase and hence be capable of less binding interaction. 
This model proposes that the membrane itself is part of the HTX 
binding site, serving to form a fluid hydrophobic region capable 
of accommodating variously shaped hydrophobic groups. It is 
possible that the membrane:alkylguanidine partition coefficients 
may fortuitously mimic the hydrophobic interaction between the 
ligand and a hydrophobic site of the protein, though it is 
difficult to imagine a protein hydrophobic site which could 
provide strong, predictable interactions for linear alkyl chains, 
cyclic chains and HTX with its large hydrophobic surface on 
the side opposite its binding groups. This is especially true 
in light of the lack of dependence on the stereochemistry of 
the number two position of the HTX azaspiroundecane system. 
The complete loss of the pentylgroup attached to the number 
2 carbon results in a loss in binding energy (~G) of 2.0 kcal/ 
mole as calculated by the formula ~G = RTln K eq This is in 
only qualitative agreement with the above model, as the energy 
of transfer for a pentyl group from water to hydrocarbon may be 
calculated (Tanford, 1973) to be -5.7 kcal assuming only one 
terminal methyl group. The loss of 2.2 kcal of binding energy 
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Figure 16. A possible model for ligand binding to the HTX 
site. The ligand partition coefficient between the aqueous 
and membrane lipid phases is denoted by a, while B 
represents partitioning of the AcChR bound ligand between 
aqueous and lipid phases. Bis presumably a function of a. 
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incurred by adding a terminal hydroxyl group to the pentyl chain 
is also qualitatively consistent with the model, as the 6G of 
transfer of pentyl alcohol from pure alcohol to water has been 
determined (Kinoshita et al.,1958) to be 3.2 kcal, a value which should 
be higher for transfer from hydrocarbon to water. The disparity 
between the observed values for 6G and those calculated from 
assumptions based on transfer of pure aliphatic compunds into 
pure hydrocarbon phases may be due to incomplete transfer of 
the groups in question or to perturbations of the membrane 
structure induced by the bulk of the HTX molecule. 
Based on the relative .Kds of octylamine and octylguanidine, 
I expected a large loss of binding energy for dehydroxyl-HTX (V) 
as compared to H12 -HTX. This turned out not to be the case 
(Table III) and, in light of the model, I feel this is best 
explained by the increased hydrophobicity of the dehydroxy-HTX, 
which was noticeably less water soluble than H12 -HTX. 
The competition between Carb and alkyl guanidines was weak, 
with Kd s almost 10 4 higher than ·the Kd of Carb for the agonist 
site. I believe the binding is due to the simple charge-charge 
interaction seen at the agonist site with other positively 
charged molecules (Elliott, et al., 1980. It has been reported 
(Narahashi, 1980) that methyl guandidine inhibits from end 
plate potentials with a KI of about 1 mM and this is in good 
agreement with the value of Kd seen for Carb inhibition with 
this molecule. Octylguanidine was reported to have a KI of 
about 1 µM in the same study, a value which is in agreement with 
90 
the 1.5 µM Kd I have determined for octylguanidine by competition 
with [ 3H]-H12-HTX. 
I attempted to determine the pK of the AcChR group respons-a 
ible for HTX binding. Due to denaturation of the AcChR below 
about ph 6.0, I can report here only that the pK is below 6.5. 
a 
Thus the data do not allow estimation of the hydrophobicity 
of the environment of the group in question. 
The results with alkylguanidines are similar to results 
previously reported for interaction of alkylguanidines with the 
Na+ channel of~ electricus (Reed and Trzos, 1979), in which 
the same dependence of Kd upon chain length was observed. A 
similar chain length dependence was observed when alkyl quaternary 
ammonium ions were used to inhibit conductance in K+ channels 
(Armstrong, 1971). It is interesting that in the cases of 3 
different ion transport channels involved in neurotransmission, 
all possessed a sensitivity to a positively charged amphipathic 
molecule that was affected by the chain length of the hydrophobic 
portion of the ligand. I found no competition between TTX and 
[ 3H]-H 12 -HTX binding to AcChR and no competition was found 
between H8 -HTX and [3H]-TTX for the binding site on the voltage 
sensitive Na+ channel (W. Agnew, personal communication). Thus 
direct homology between the sites on Na+ channel and AcChR is 
not likely. 
There is little to be said for the results of the 
dansylguanidine experiments. Any specific binding of the 
ligand was apparently obscured by the much larger 
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non-specific fluorescence enhancement which we attributed to 
partitioning of the dansylguanidine into the membrane. Since 
this compound should also interact with the TTX site of the 
sodium channel (Reed and Trzos, 1979), it would be interesting 
to see if the fluorescent properties of the ligand in these 
preparations make it a viable probe for stopped-flow spectroscopy. 
[ 3H]-HTX-N 3 labeled three of the four AcChR subunits (Fig. 
12). However, H8 -HTX totally blocked binding only to the 65,000 
dal ton subunit (Fig. 14). Binding to the other two subunits 
labeled (the 40,000 and 50,000 dalton subunits) was also decreased 
to some extent by H8 -HTX, but this was probably due to compe-
tition of H8 -HTX and [ 3H]-HTX-N 3 for a limited number of hydro-
phobic non-specific "sites". When 90,000 dalton protein was 
present in the preparations, it too was strongly labeled and 
this labeling was decreased by H8 -HTX. The 90,000 dalton protein 
was also labeled in experiments using procaineamide azide 
(Blanchard and Raftery, . 1978), so it seems likely that this 
protein was labeled due to the presence of hydrophobic areas 
which non-specifically bind hydrophobic ligands. Removal of the 
90,000 dalton protein has no known effect on AcChR function 
(see Chapter III). The amount of labeling to the 65,000 dalton 
and 50,000 dalton subunits was saturable, whereas incorporation 
of label into the 90,000 and 40,000 dalton subunits seemed 
proportional to the concentration of label up to the highest 
[3H]-HTX-N 3 concentration used (28 µM). At 6 µM [
3H]-HTX-N 3 , 
the optimal concentration, the 40,000 dalton band had four times 
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more label than either the 65,000 or 50,000 dalton bands which, 
given the 2:1:1 subunit stoichiometry of the AcChR, indicates 
that the 40,000 dalton subunit was binding twice as much label 
as either of the other two subunits labeled. The 60,000 dalton 
subunit was not labeled even when 28 µM [ 3H]-HTX-N 3 was used. 
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CHAPTER II 
Proton magnetic resonance studies of cholinergic ligand binding 
to the acetylcholine receptor in its membrane environment. 
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INTRODUCTION 
In recent years the application of NMR methodology to 
biological systems has yielded a wealth of information regarding 
structural and functional aspects of enzymes and proteins in 
solution. This has been achieved mainly by approaches such as 
direct observation of nuclei of constituent amino acid sidechains 
of the macromolecules or observation of perturbations of ligand 
nuclei exchanging between free and bound states under different 
sets of conditions. In order to extend such methods to the study 
of membrane-bound macromolecules, the second approach is the more 
feasible provided that (i) a high concentration of membrane-bound 
ligand binding sites can be obtained, (ii) a ligand is available 
that is readily observable by using current NMR instrumentation, 
and (iii) the ligand binding parameters are suitable for study 
of the exchange between free and bound states. 
The third condition is not fulfilled by agonists such as 
acetylcholine (AcCh) and carbamylcholine (Carb), because these 
ligands have too high an affinity for the AcCh receptor (AcChR) 
under equilibrium conditions. However, all the necessary condi-
tions are met by using choline as a ligand that binds to membranes 
highly enriched in the postsynaptic nicotinic AcChR. Titration 
of membrane fragments enriched in AcChR (Duguid and Raftery, 
1973; Reed, et al., 1975; Elliott, et al., 1979) with choline, 
a known partial agonist (Adams and Sakmann, 1978), has allowed 
determination of the choline dissociation constant from the 
concentration dependence of the observed linewidth, because 
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nonspecific broadening was determined to be negligible by a similar 
titratioti of membrane fragments in which the AcChR agonist 
binding sites were blocked with a-bungarotoxin (a-BuTx). The 
temperature dependence of the dissociation constant and that of 
the methyl linewidth at a fixed choline concentration contained 
the data necessary for determination of the enthalpy of binding 
and for estimation of the apparent dissociation rate constant and 
the respective activation energy. Thus, it was possible to apply 
a highly informative spectroscopic technique to the study of 
membrane-bound receptors for elucidation of structural and kinetic 
properties. 
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MATERIALS AND METHODS 
Membrane fragments enriched in AcChR were prepared using 
sucrose density centrifugation with a Beckman VTi-50 (Elliott, 
et al., 1979) rotor, as described in Chapter I. The enriched 
membranes were then centrifuged at 100,000 x g, and the pellet 
was resuspended in 0.01 M sodium phosphate buffer made with 
99.7% 2 H2 0. After a minimum of 2 hours the membranes were again 
pelleted and resuspended in 0.01 M sodium phosphate buffer made 
with 100% 2 H2 0 (Bio-Rad, Inc., Richmond, California). This last 
procedure was repeated and the preparation was then homogenized 
twice for 30 sec with a VirTis 23 homogenizer operating at 
maximal speed. The two hour equilibration periods were necessary 
to achieve the low levels of protiated water required in the 
experiments, as the membrane fragments retain considerable amounts 
of water in the bilayer. The final concentration of AcChR, 
expressed as [ 125 I]-a-BuTx binding sites was typically 10 µM. 
The concentration of a-BuTx binding sites was determined 
using the disc assay (Schmidt and Raftery, 1973) in which 
complexes of AcChR and [ 125 I]-a-BuTx are adsorbed to DEAE-paper 
discs, which are then washed to remove uncomplexed a-BuTx and 
counted in a Beckman y-Ray counter. Protein concentrations 
were determined using the method of Lowry (Lowry, et al., 1951). 
The inhibition constant of a ligand for the agonist site 
can be determined by measuring the dependence of the initial 
rate of [ 125 I]-a-BuTx:AcChR complex formation (Blanchard, et al., 
1979). At a time defined as zero, membrane fragments with a 
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given concentration of the agonist are mixed with [ 125 I]-a-BuTx 
and aliquots are taken at given time intervals. These aliquots 
are immediately applied to the DEAE paper disc, which quenches 
the complexing reaction. The discs are washed to remove un-
complexed [1 25 I]-a-BuTx and their content of radioactivity is 
determined. Thus a hyberbolic curve of radioactive a-BuTx 
bound versus time can be plotted and the initial rate determined 
in the presence of different agonist concentrations, this 
dependence can then be interpolated back to an inhibition 
constant for the agonist. This method was used to confirm 
the Kd for choline determined by NMR. 
In order to minimize the content of protiated water in the 
stock solutions, the sodium chloride, choline and Carb used in 
the experiments were dissolved in 99.7% 2 H2 0 and then lyophilized. 
Stock solutions were then prepared from these reagents using 
100% 2 H2 and kept tightly sealed. At all stages of the 
titrations, care was taken to minimize atmospheric contact 
with the solutions in order to maintain low levels of protiated 
water. These low levels were necessary as the nuclear magnetic 
resonance signals being observed were quite close to the 
resonance frequency of the proton in 2 H0 1H and were hence 
easily obscured if the protiated water content was too high. 
Excessive protiated water content also caused dynamic range 
problems with the spectrometer. 
lH NMR spectra were recorded using a Varian XL-100-Vl5 
spectrometer in the Fourier transform mode locked on the 2H20 
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signal of the sample. The temperatures were controlled using 
a Varian variable temperature unit. Sample volumes between 
1.5 to 2.0 ml were placed in 12 mm sample tubes. These small 
volumes necessitated the use of Teflon anti-vortex plugs 




When a relatively low concentration of choline (200 µM) 
was added to a suspension of AcChR enriched membrane fragments 
at moderate concentration (10 µMin a-BuTx binding sites), 
the linewidth of the three equivalent choline methyl groups 
was observed to be substantially broader than that of choline 
alone in aqueous solution (Fig. 1, upper). At a ratio of 
choline to AcChR a-BuTx binding sites of 10:1, a wide (~15 Hz) 
line was observed and, as the ratio of choline to AcChR was 
increased, the observed linewidth decreased until an apparently 
constant value was obtained when the choline to AcChR site 
ratio was on the order of 100:1. When the same experiment was 
performed with membrane fragments that had been treated with 
a-BuTx, a constant and narrow linewidth was observed, independent 
of the choline concentration. These observations are consistent 
with the hypothesis that the linebroadening was due to a specific 
interaction of choline with the AcChR. No change in chemical 
shift was observed, and it was considered that this quantity 
was the same for both bound and free states. In the case of 
weak binding (see below), the free species is the one observed 
and, if there is only one bound state, the equation describing 
the linewidth is: 
(1) 
where r b is the width of the observed lorentzian line at half 
0 s 
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its height, r b is the width of the line under conditions in 
0 s 
which the specific broadening is abolished, lb/1
0 
is the 
fraction of the ligand bound (with free ligand in great excess 
over bound), and T2b and tb are the spin-spin relaxation time 
and average residence time of the bound ligand, respectively 
(Swift and Connick, 1962). At a given temperature, T2b and tb 
are constant, and the observed broadening is solely a reflection 
of the fraction of the ligand bound. Thus, the dissociation 
constant for the ligand may be obtained by plotting (robs - rF)- 1 
versus total ligand concentration, 1 o' (Fig. 1 ' lower), because 
expressing lb/lo in terms of 1 0 and Kd results in: 
1 n(T2b + tb) 
+ Kd) (2) = (lo r - r r obs F 0 
Here, r
0 
is the total concentration of binding sites and Kd is 
the apparent dissociation constant of the complex. 
Several titrations of choline-receptor association at 
different temperatures were conducted to determine the thermo-
dynamic parameters of the interaction between choline and the 
AcChR. For the equilibrium constant little or no temperature 
dependence was found within our limits of error (Table 1), and 
it was concluded that 6H for this binding was small. 
The temperature dependence of the slopes (S) of the semi-
reciprocol plots, as in Fig. 1 lower, also contains important 
information: 
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Figure 1. (Upper) Proton magnetic resonance spectra of choline 
methyl groups at various concentrations of choline. All 
spectra were recorded in 10 mM P. buffer ( 2 H20), pH 7.4, l 
containing membrane fragments with 5 µM AcChR at 4.6°C. 
The top spectrum was recorded 20 min after the addition 
of 10 µM a-BuTx to the above solution in which the choline 
concentration was 1.1 mM. (Lower) Plot of the spectra in 
Upper by using Eq. 2; (robs - rF)- 1 versus [choline]. 










Cl) T l/i Q) 0.2 ~ ~ 













The two parameters, T2b and tb, are expected to have opposite 
temperature dependences (Sykes, et al., 1970; Dwek, 1973). We 
observed a decrease in slope with increasing temperature (see 
Table 1) and an increase in the observed linewidth at low 
saturation of the AcChR with choline. This indicates (see 
Discussion) that tb > T2b. Because tb, the lifetime of the 
complex, is equal to l/kdiss' where kdiss is the (apparent) 
dissociation rate constant of the complex, one estimates from 
the data in Table 1 that kd. > 1.6 x l03s- 1 at 18°C. 
lSS -
The temperature dependence of the slope (Eq. 3) yields the 
activation energy for kdiss with Ea(kdiss) = 5 ~ 2 kcal/mol. 
A statistically independent estimate of E (kd. ) is obtained 
a lSS 
from an Arrhenius plot of log (robs - rF) at a fixed choline 
concentration versus i/T (see Fig. 2). Because Kd is essentially 
temperature independent in the temperature range studied (see 
above and Table 1), the observed slope in Fig. 2 reflects the 
activation energy of the process characterized by tb' which in 
this case was found to be 5.5 kcal/mol. Both values for Ea are 
in good agreement. 
Competition Studies 
Competition studies with radiolabeled ligands have shown 
that different agonists apparently bind to the same site of the 
AcChR from Torpedo (Raftery, 1975; Eldefrawi and Eldefrawi, 
1977) or Electrophorus (Fu, et al., 1977) membranes. Therefore, 
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Figure 2. Arrhenius plot constructed by using data from proton 
magnetic resonance spectra of a mixture of 0.7 mM choline 
and AcChR enriched membrane fragments (1 2 51-labeled a-BuTx 
site concentration = 22 µM) recorded at various temper-
atures. The plot is of log (robs - TF) versus l/T and 
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addition of the agonist Carb should reduce line broadening due 
to its interaction with the binding site of the ligand being 
observed (choline). Because Carb affinity for the AcChR is 
much higher than that of choline (Eldefrawi and Eldefrawi, 1977; 
Blanchard, et al., 1979; Schimerlik, et al., 1979; Quast, et al., 
1979), a low concentration of Carb would be undetected in the 
NMR spectrum but would be expected to narrow the choline signal 
substantially. This behavior was observed, and a complete 
titration with Carb at fixed choline concentration (Fig. 3) 
resulted in an apparent Kd for Carb of 3.5 ~ 0.1 µM when the 
data were plotted by using Eq. 2. This value must be corrected 
for the effect of choline competition by using the formula Kd = 
K [l + S /K ]- 1 , where Kd is the true dissociation constant, app o o 
K is the apparent dissociation constant measured, S is the app o 
concentration of the competing ligand (choline in this case), 
and K
0 
is the dissociation constant of this competing ligand. 
The corrected Kd for Carb was 0.5 + 0.1 µM. 
It has been shown that monovalent cations decrease the 
second-order rate constant for [ 125 I]-a-BuTx binding to 
(Schmidt and Raftery, 1974) and the affinity of the fluorescent 
antagonist l,10-bis(3-aminopyridinium)-decane diiodide 
(Martinez-Carrion and Raftery, 1973) for detergent solubilized 
purified AcChR. Both these studies showed that monovalent 
cations have apparent binding constants of 5 mM. On the other 
hand sodium chloride, in the 5-50 mM range, had little or no 
effect on the binding of the agonist AcCh to solubilized 
110 
Figure 3. (Lower) Titration of choline-AcChR complex with Carb. 
The experiment monitors the variation of the choline 
linewidth with Carb concentration. The mixture contained 
AcChR-enriched membrane fragments (20 µM 12 51-labeled 
a-BuTx sites) and 0.9 mM choline in 10 mM P. buffer ( 2 H2 0), l 
pH 7.4, at 15°C. The plot shows (robs - rF)- 1 versus 
[Carb]. The line is a weighted linear least-squares fit, 
giving an apparent Kd of 3.5 ~ 0.1 µM. (Upper) Titration 
of choline-AcChR complex with NaCl. The conditions are as 
in Lower, with (robs - rF)- 1 versus [NaCl] plotted. The 
line is a weighted least-squares fit, giving an apparent 
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purified AcChR (T. Moody and M.A. Raftery, unpublished results). 
By using the same methods employed for Carb, we obtained a K. 
l 
(apparent) for NaCl of 260 ~ 10 mM, indicating a much weaker 
effect of salt on the binding of the partial agonist choline 
than was observed on the binding of antagonist. 
The dissociation constant for choline was also determined 
by inhibition of the kinetics of 1 25 I-labeled a-BuTx-AchChR 
association (Blanchard, et al., 1979) in buffer of composition 
identical to that used in the NMR experiments. The value 
obtained, 120 ~ 50 µM, was in good agreement with that obtained 
from the NMR data (190 + 65 µM, Table I). The same experiment 
performed in buffer made in protiated water resulted in essen-
tially the same Kd. 
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DISCUSSION 
The studies described are based on observation of a 
perturbation in the 1H-NMR spectrum of a partial agonist induced 
by binding interactions with the AcChR in its native membrane 
environment. The effect is specific because it can be completely 
blocked by pretreatment of the membranes with a-BuTx, which 
specifically competitively blocks ligand binding to the AcChR 
(Quast, et al., 1978). The binding of a-BuTx should not affect 
any linebroadening due to non-specific interactions, and the 
data for rF therefore include all linebroadening except that 
due to specific ligand binding at the AcChR agonist binding site. 
The data were analyzed according to Eq. 1, which is a special 
case of a more general formula derived by Swift and Connick 
(Swift and Connick, 1962) from modified Bloch equations contain-
ing terms for chemical exchange (McConnell and Berger, 1957). 
The main assumptions leading to Eq. 1 are (i) there are only 
two kinds of environment for the nucleus (i.e., bound and free), 
(ii) the free nuclei are always in excess over the bound species 
and are therefore the ones observed, and (iii) there is no change 
in chemical shift due to binding. 
Assumptions ii and iii were experimentally fulfilled in 
that we did not observe a chemical shift difference between 
bound and free ligand, and the concentrations of ligand binding 
sites used were R
0 
~ 10 µM << Kd ~ 200 µM, so that at all ligand 
concentrations only a small fraction of the total ligand present 
was bound. Assumption i was made for the sake of mathematical 
simplicity because the original formulae of Swift and Connick 
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are complex and would not allow unambiguous determination of 
the many parameters they contain. 
Plotting the observed half-width of the resonances according 
to Eq. 2 directly yielded the equilibrium constant, Kd. The 
value of 190 + 65 µM for choline is in agreement with that 
obtained from inhibition of the kinetics of 12 5I-labeled 
a-BuTx binding in the same medium (120 ~ 50 µM). These values 
are more than 2 times higher than those determined in 4 mM 
protiated buffer containing calcium, where a value of 50 + 4 µM 
was found using inhibition of [ 12 51]-a-BuTx binding (Blanchard, 
et al., 1979) and a value of 25 µM was found using the fluorescent 
probe ethidium (Schimerlik, et al., 1979; Quast, et al., 1979). 
A similar effect was observed with Carb, for which a Kd of 
0.5 + 0.1 µM was observed from competition with choline in the 
NMR experiments reported here, using calcium-free buffer. This 
value compares well with the value of 0.33 + 0.05 µM determined 
by using radioactively labeled Carb in calcium-free buffer 
(Schimerlik and Raftery, unpublished). However, values for Kd 
of 0.05 - 0.12 µM were reported when the determinations were 
done in calcium containing buffers using several experimental 
procedures (Raftery, et al., 1975; Quast, et al., 1978; Quast, 
et al., 1979, Schimerlik, et al., 1979). 
The finding of similar equilibrium constants for choline 
by inhibition of [ 12 5I]-a- BuTx binding kinetics in protiated 
and deuterated buffers seems to indicate that the lack of 
calcium is responsible for the high Kd values observed. This 
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conclusion is in agreement with the observation (Cohen, et al., 
1974) that calcium increases the affinity of the membrane bound 
AcChR for cholinergic ligands. Choline titrations at different 
temperatures showed essentially no temperature dependence of 
the equilibrium constant, and the enthalpy of binding was 
estimated to be < 1.5 kcal/mol. Therefore, binding of choline 
to AcChR is mainly entropy driven [~S ~ 20J/(mol•K)]. The 
increased entropy of the complex (compared to the free compo-
nents) could be due to higher internal flexibility in the 
complex or a decreased exposure of the hydrophobic surf aces 
to the solvent. A ligand-induced conformational change 
of the AcChR provides a plausible explanation for both cases. 
There is independent evidence for such an agonist induced 
conformational change of the AcChR (Grunhagen, et al., 1977; 
Quast, et al., 1978; Schimerlik, et al., 1979), though this is 
the first report of a change in entropy accompanying agonist 
binding to membrane-bound AcChR. With solubilized purified 
AcChR from Electrophorus, a considerable positive change in 
enthalpy (~H ~ + 20-30 kcal/mol) was observed which was over-
compensated by unusually large changes in entropy c~s = +100-
120 J/mol·k) (Maeliche, et al., 1977). Detergent solubilized 
AcChR of Torpedo is known to have markedly different agonist 
binding properties when solubilized (Blanchard, et al., 1979). 
Further kinetic results can be inferred from the observed 
temperature dependence. The denominator of Eq. 1 is the sum of 
two terms, T2b and tb. Because l/tb is the average exchange 
rate of the ligand-receptor complex, the data obtained from a 
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titration allows placement of a lower limit on the exchange rate. 
How close this limit is to the actual value depends on the 
contribution T2b makes to the denominator. T2
b is not easily 
evaluated; however, the temperature dependence of the linewidth 
gives a good indication of the relative sizes of T2b and tb 
due to their opposite temperature dependences (Sykes, et al., 
1970). The exchange rate (l/tb) increases with temperature, 
exposing a larger proportion of the total choline spin population 
to the bound environment, and this results in a broadening of 
the observed line as temperature increases. T
2
b is expected to 
have the opposite behavior because the faster molecular motions 
associated with higher temperature usually result in decreased 
effectiveness of relaxation processes and thus larger values 
for T2b (Sykes, et al., 1970). A system in which T2b was the 
dominant term in Eq. 1 would be expected to have a decreased 
linewidth at a higher temperature. The observation that the 
linewidth increased with temperature (Fig. 2) indicates that 
tb is the dominant term, and, therefore, one may place meaning-
ful lower limits on the dissociation rate of the agonist from 
the receptor complex. The dissociation rates determined 
(Table 1) are on the order of 2.5 x 10 3s- 1 at room temperature. 
assuming a simple L + R~LR mechanism, the lower limit of the 
association rate constant, kass' can be calculated from Kd and 
kd. as k = kd. /Kd = 1.5 x 107 M-1 
lSS ass lSS Values in this 
range have been observed in stopped-flow experiments for binding 
a few agonists to membrane-bound (Griinhagen, et al., 1977; 
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Barrantes, 1978) to Torpedo AcChR as well as with Electrophorus 
electroplax in electrophysiological measurements (Sheridan and 
Lester, 1977). These values are on the threshold of being 
diffusion limited. 
The following mechanism has been proposed for the mechanism 
of action of the partial agonist choline (Adams and Sackmann, 
1978): 
L + R LR ~LR* 
where LR* is the open channel form of the AcChR. This step 
is much less frequent when L is a partial agonist than is the 
case when L is an agonist such as acetylcholine. While this 
model is now known to be oversimplified (Dunn, et al., 1980), 
it is adequate to explain the NMR data if one takes into account 
the fact that choline is known (Quast, et al., 1978) to convert 
the AcChR into the closed channel high ligand affinity state 
thought to be an in vitro correlate of desensitization 
(Heidmann and Changeux, 1978). This is the state the AcChR 
was in under the equilibrium conditions of these NMR experiments, 
so that the observed mechanism was L + R~LR', where LR' was 
the closed channel, high affinity state of the AcChR. 
In conclusion, NMR has been shown to be a promising experi-
mental method for investigating agonist binding to the purified 
AcChR in its membrane environment. Results that can be compared 
agree well with those obtained by using other methods, compli-
cations due to nonspecific binding effects or probe-induced 
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artifacts can be avoided, and the approach has provided a means 
of estimating parameters not previously determined. 
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CHAPTER III 
Agonist induced desensitization and its modulation by local 




After prolonged exposure to relatively low concentrations 
of agonist, the in vivo AcChR becomes electrophysiologically 
unresponsive to agonist concentrations that would normally 
generate a physiological response (Katz and Thesleff, 1957). 
The original investigators termed this phenomenon "desensiti-
zation" and proposed a two-state model which was capable of 
explaining their observations. The two-state model proposed 
that the AcChR has two affinity states for agonists and that 
the transition from low affinity to high affinity is mediated 
by the agonist itself. · The high affinity state would correlate 
with a non-conducting form of the AcChR. Further studies 
(Rang and Ritter, 1969, 1970) found that this high affinity 
state is not ligand specific; desensitization induced by agonists 
increased the AcChR's affinity for certain antagonists as well. 
The electrophysiological observations have been extended 
with in vitro studies of AcChR response to agonists. Agonist 
induced increase in ligand affinity has been detected (Weber, 
et al., 1975; Weiland, et al., 1976; Lee, et al., 1977) and 
this increase is thought to be an in vitro correlate of the 
desensitization observed electrophysiologically. 
The in vitro observations could be qualitatively explained 
with a two state model (Weber, et al., 1975; Weiland, et al., 
1976; Lee, et al., 1977), though quantitative agreement of the 
observations made in Ringer's buffer could not be achieved 
with a two-state model (Quast, et al., 1978). Rapid kinetics 
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studies using intrinsic AcChR fluorescence (Bonner, et al., 
1976; Barrantes, 1976) and extrinsic probes (Griinhagen and 
Changeux, 1976; Quast, et al., 1978; Schimerlik, et al., 1979a>b) 
have been done to allow quantitative interpretation of confor-
mational changes thought to represent desensitization. The 
studies performed with quinacrine (Griinhagen and Changeux, 
1976) are complicated by the fact that quinacrine was in the 
same study shown to be a local anesthetic. Local anesthetics 
affect desensitization, as will be discussed below. Ethidium 
bromide was used in another kinetic study (Schimerlik, et al., 
1979a,b; Quast, et al., 1978). This probe does not have 
local anesthetic properties and data collected using it would 
best be fit with a sequential binding model (Quast, et al., 
1978, 1979). 
Local anesthetics block the in vivo response of AcChR to 
agonists (Ruff, 1976; Neher and Steinbach, 1978), 
possibly by binding to the open channel form at the AcChR and 
blocking conductance. Local anesthetics also increase the 
rate of in vivo desensitization (Magazanik and Vyskocil, 1973). 
The rate at which the affinity for agonists changes 
in vitro is also affected by the presence of local anesthetics. 
Dibucaine, for example, increases the rate of desensitization 
in vitro while tetracaine has the opposite effect (Blanchard, 
et al., 1979a). As in the case of in vivo desensitization, it is 
possible that the in vitro effects are due to direct interaction 
of the ligand with the protein; alternatively, there is the 
possibility that the effect is mediated by interaction of 
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the ligand with the lipid phase causing a change in AcChR 
conformation. 
The nicotinic AcChR of the electric ray is composed of 
four types of subunits of 40,000, 50,000, 60,000 and 65,000 
daltons (Weill, et al., 1974; Raftery, et al., 1974; Hucho, 
et al., 1978; Chang and Bock, 1979), although this composition 
is not universally held to be the case (Sobel, et al., 1977; 
Neubig, et al., 1979). Recently, however, the four subunits 
have been shown to all be part of the AcChR by amino acid 
sequence analysis (Raftery, et al., 1980). It has been shown 
that specific binding of a local anesthetic analog occurs on a 
separate polypeptide of 43,000 daltons (Sobel, et al., 1979; 
Blanchard and Raftery, 1979). This binding may in some way be 
associated with the AcChR and the 43,000 dalton protein has 
been the focus of much recent research (Neubig, et al., 1979; 
Changeux, et al., 1979; Moore, et al., 1979; Elliott, et-al., (1979). 
The recent observation (Neubig, et al., 1979; Elliott, et 
al., 1980) that a brief exposure of the AcChR enriched membrane 
fragments to high pH removes many extrinsic membrane proteins, 
including the 43,000 dalton polypeptide, has made it possible to 
further clarify the subunit composition of the membrane bound 
AcChR since only three (Neubig, et al., 1979) or all four 
(Elliott, et al., 1980) of the receptor subunits remain. Such 
alkali treated membrane fragments have been shown to possess 
the same activity as untreated membranes in terms of agonist 
mediated ion flux (Moore, et al., 1979), histrionicotoxin 
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binding (Elliot~, et al., 1970), Carb binding (Dunn, et al., 
.1980), desensitization capability (Elliott, et al., 1979, 
1980; Changeux, et al., 1979) and some aspects of local 
anesthetic modulation of the desensitization rate in that the 
local anesthetic trimethisoquin was found (Changeux, et al., 
1979) to increase the rate of desensitization. The question 
still remains whether or not the different types of modulation 
elicited by t he different local anesthetics are retained in 
alkali treated membranes containing only the AcChR protein. 
It has been demonstrated that several different local anesthe-
tics displace specifically bound [ 3H]-H 12 -HTX (Elliott, et al., 
1979; Blanchard, et al., 1979) and that this toxin binds 
specifically to the AcChR (Elliott and Raftery, 1979; Elliott, 
et al., 1979; Neubig, et al., 1979, Eldefrawi, et al., 1977} 
rather than to proteins distinct from the AcChR (Sobel, et al., 
1978; Eldefrawi, et al., 1979). However, it has not been shown 
that the binding of the various agents is a strictly 
competitive process and the possibility remains that some local 
anesthetics that modulate the AcChR's affinity for agonists 
exert their effects by conformationally linked processes 
involving entities other than the AcChR. 
I report here that membrane fragments containing only 
the AcChR protein complex exhibit both positive and negative 
modulation of the rate of agonist induced ligand affinity in 
the presence of dibucaine and tetracaine, respectively. 
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MATERIALS AND METHODS 
I. AcChR Enriched Membrane Fragments 
Approximately 500 g of frozen electric organ from 
T. californica was broken into small pieces and mixed with 
500 m1 of buffer [10 mM NaPi, 5 mM EDTA, 0.02% NaN 3 , 5 mM 
iodoacetimide, 10 mM PMSF pH= 7.4). This was ground for 
2 minutes in a Waring blender, then reground for 4 x 30 seconds 
at 30,000 rpm in a Virtis 60 homogenizer. Large particles and 
connective tissue were removed by a 10 minute centrifugation 
at 5000 rpm in a Sorval GSA rotor. The supernatant was then 
centrifuged 60 minutes at 30,000 rpm in a Beckman 35 rotor. 
The pellet was resuspended in 10 mM NaPi (pH 7.4) 1 mM EDTA 
by using 2 x 30 second homogenizations with a Virtis 60 
homogenizer. Sucrose and NaCl were added to achieve final 
concentrations of 30% (w/w) and 0.4 M> respectively. 
The sample (10 ml) was layered on a discontinuous sucrose 
gradient with steps of 5 ml 50% w/w, 5 ml 39% w/w, and 12 ml 
of 30% w/w, all in 0.4 M NaCl, 10 mM Pi (pH= 7.4) 1 mM EDTA. 
This buff er was used to adjust the final volume of each tube 
to the rim. The loaded tubes were centrifuged for 60 minutes 
at 45,000 rpm in a VTi 50 rotor using a slow acceleration 
accessory and Beckman L-5 centrifuge. After centrifugation 
the membrane fragments were observed to be in three bands. 
The middle band, consisting of particles with a density of 
1.18 g/cc, was aspirated away from the gradients, diluted 
with plain buffer and centrifuged for 60 min at 35,000 RPM in 
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a Beckman 35 rotor. The memb~anes were resuspended in a small 
amount (~10 ml) of Torp~do Ringer's buffer using a Virtis 
homogenizer. This preparation has been described in detail in 
Elliott, et al., 1980). 
II, Alkali Treatment of AcChR Enriched Membrane Fragments 
Alkali treatment of the membrane fragments from the above 
procedure was adapted from the protocol reported by Steck and Yu 
(1973) for erythrocyte ghosts. Membrane fragments containing 
approximately 50 mg of total protein were pelleted, resuspended 
in distilled water with a Virtis homogenizer and pelleted again. 
They were then resuspended in 80 ml of cold distilled water using 
a Virtis homogenizer for 2 x 30 sec. The suspension was then 
adjusted to pH 11.0 using 0.5% NaOH. This pH was maintained 
for 30 minutes at 4°, with small additions of NaOH. The mem-
branes were then pelleted by centrifugation for 30 minutes at 
30,000 rpm in a Beckm~n type 35 rotor. A Virtis homogenizer 
was used to resuspend the pellet in Torpedo Ringer's buffer. 
III. Affinity-State Assay 
The state of affinity of the AcChR for the agonist Carb 
was determined by a competitive binding assay (Quast, et al., 
1978). The rate of a-BuTx-AcChR complex formation was deter-
mined by adding 2.6 x l0-7M [1 2 5I]-a-BuTx to 5 x 10- 7M AcChR 
in Ringer's buffer and pipetting 50 µL of this solution onto 
2.4 cm Whatman DE-81 filter paper discs at given time intervals, 
after which th8 discs were washed and their radioactivity 
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measured in a y-counter. This was repeated with an identical 
solution which had been preincubated for 30 minutes with 1 µM 
Carb to insure that all AcChR was in the high affinity state. 
Having established the two control rates, the toxin on-rate 
was measured when Carb was added simultaneously with a-BuTx. 
The total AcChR population is a mixture of receptors of either 
high or low affinity, and thus the observed rate of a-BuTx-
AcChR complex formation is composed of two components; one in 
which a-BuTx competes with Carb for receptors with low Carb 
affinity, and a slower rate in which toxin competes with Carb 
for those receptors having the higher (~1000 X) agonist affinity. 
The closer the net rate is to the previously measured toxin 
on-rate in the absence of Carb, the greater the proportion of the 
receptor population in the low agonist affinity state. Experi-
ments in which the rate of the agonist-induced affinity state 
transition were measured were performed only with preparations 
in which the majority . of receptors were in the state of low 
affinity for agonists. 
The rate at which agonists induced the affinity state 
change is affected by some local anesthetics and this effect 
was quantitatively assayed by a modification of the affinity 
state assay. The appropriate local anesthetic was added to the 
AcChR in Ringer's buffer and after a minimum of 30 minutes, 
a-BuTx Carb competition assays were performed with various 
Carb preincubation times, allowing the transition rate from low 
to high affinity to be monitored. The rate was calculated from 
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these data using the equation derived by Blanchard, et al. 
(1979a); 
-k't K = (k - k ) e + k (app) o oo oo 
where k
0 
was the rate of toxin binding in the presence of 1 µM 
Carb without preincubation, k was this rate in 1 µM Carb when 
00 
all AcChR was in the high affinity state (30 minutes preincu-
bation) and k' was the rate of transition in AcChR affinity 
to agonist. 
IV. Miscellaneous 
AcChR concentration was determined by complexing the 
AcChRs with saturating amounts of [ 125 I]-a-BuTx and adsorbing 
these complexes to Whatman DE-81 DEAE paper discs. Uncomplexed 
toxin, which has a positive charge, was removed by washing the 
discs in 10 mM phosphate (pH 7.4) 100 mM NaCl buffer with 0.1% 
Triton X-100. The washed discs were then assayed for radio-
activity (Schmidt and Raftery, 1973). Protein concentrations 
were determined using the method of Lowry, et al. (1951). SDS 




The membranes purified by sucrose gradient centrifugation 
had a complex polypeptide composition as evidenced by SDS gel 
electrophoresis and had a specific activity of ~1 nmole 
[1251]-a-BuTx binding sites per mg protein. Following alkali 
treatment the resultant membranes consisted of only four 
principal proteins staining intensely with CBB and migrating 
as 40, 50, 60 and 65 x 103 dalton components on gel electro-
phoresis (Fig. 1). The specific activity of these membrane 
preparations was typically ~3 nmoles [ 125 1]-a-BuTx bound per 
mg protein, a value close to that previously reported (Elliott, 
et al., 1980). The four polypeptides are those previously 
reported for detergent solubilized AcChR purified by affinity 
chromatography (Raftery, et al., 1974; Weill, et al., 1974; 
Hucho, et al., 1978; Chang and Bock, 1979; Deutsch and Raftery, 
1979) from Torpedo californica and other related species 
(Deutsch and Raftery, 1979). The supernatant from the alkali 
treatment contained principally a 43,000 dalton polypeptide and 
the soft pellet a 90,000 dalton polypeptide, both major compo-
nents of the membranes before the base extraction (Fig. 1). 
Thus the hard pellet represents a membrane fraction essentially 
devoid of these two major components as well as other minor 
contaminants and is composed almost entirely of the four AcChR 
subunits. The polypeptide composition of this preparation is 
not universally agreed upon since others have reported that 
it contains three, not four, of the AcChR subunits (Neubig, 
131 
et al., 1979; Changeux, et al.l 1979), i.e., those of 40, 50 
and 65 x 10 3 daltons. Based on the recent finding that all 
four of the AcChR subunits are homologous polypeptides (Raftery, 
et al., 1980) it was concluded that all are part of a pentameric 
receptor complex with a stoichiometry of 2:l :l:lfor the subunits 
of 40, 50, 60 and 65 x 10 3 daltons, respectively (Strader, 
et al., 1980) and that the 60,000 dalton polypeptide is not a 
contaminant in the preparations used here. 
The alkali extracted membranes underwent a Carb mediated 
affinity state change in a manner similar to the untreated 
membranes. This was demonstrated using the effects of Carb on 
the time course of [ 125 !]-a-BuTx-AcChR complex formation 
(Fig. 2). Prolonged exposure to cholinergic ligand caused an 
increase in the affinity of the AcChR for the ligand with a 
consequent increase in its effectiveness as an inhibitor of 
( 12 51]-a-BuTx binding. The final experimental point was taken 
24 hours after the reactions were initiated and it was shown 
that the amount of [ 125 1]-a-BuTx bound at equilibrium was 
unchanged by the presence of Carb. A plot of the log of the 
difference between the amount of [ 125 I]-a-BuTx bound at each 
time interval and at equilibrium versus time was linear over 
the total time interval measured. The pseudo-first order rate 
constants derived from these data are given in Table 1. 
The effects of two local anesthetics on the rate of the 
Carb mediated affinity state change were next investigated. 
The anesthetics chosen (dibucaine and tetracaine) were those 
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that previously have been shown to have opposite effects on 
this rate in AcChR enriched membrane preparations that, however, 
still contained the contaminating polypeptides of 43 and 90 x 
10 3 daltons as well as many minor protein comp6nents. It was 
therefore not possible to state whether the effects observed 
on the rate of the Carb mediated affinity change were due to 
specific association of the local anesthetics with the AcChR 
or with other protein components of the membrane. 
In the studies described here the basic affinity state 
assay procedure was modified to include a 30 minute preincuba-
tion of membranes with the local anesthetic prior to addition 
of [1 2 5I]-a-BuTx, [1 25 I]-a-BuTx plus 1 µM Carb to start the 
reaction. As shown in Figure 3, incubation with dibucaine 
(1 µM) dramatically enhanced the Carb induced rate of trans-
ition of the AcChR from a low to a high affinity state. 
Using another common local anesthetic, tetracaine, I found 
(Fig. 3) that, as in the case of membranes not treated with 
alkali, it decreased the rate of Carb mediated conversion of 
affinity states. Thus the positive and negative modulating 
effects of dibucaine and tetracaine on the conversion are 
retained in membranes that contain only the AcChR protein and 
are devoid of a different polypeptide (43 x 103 daltons) that 
has previously been shown to interact with local anesthetics 
(Sobel, et al., 1979; Blanchard and Raftery, 1979). 
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DISCUSSION 
The magnitude of the effect of both anesthetics on the 
Carb mediated transition was similar for the alkali treated 
preparation used in the studies reported here and for the 
untracted preparations described earlier (Blanchard, et al., 
1979b). Since less than 2% of the contaminating polypeptides 
of 43 and 90 x 103 daltons remained in the base treated 
preparation the results strongly support the notion that the 
site(s) to which local anesthetics bind and exert their modu-
lating effects on AcChR conformational transitions induced by 
agonists represent binding sites on the receptor macromolecular 
complex. 
Tetracaine was found to decrease the rate of agonist 
induced desensitization, which is the opposite of what was 
reported by Weiland, et al., (1977) for this compound. However, 
the latter study used a buffer which dip not contain 
calcium and hence was not representative of physiological 
conditions. Calcium has been shown to increase that rate of 
desensitization in vitro (Lee, et al., 1977), hence the studies 
are not directly comparable. 
Dibucaine increased the rate of desensitization, in 
keeping with a recent report (Changeux, et al., 1979) which 
also described a similar effect with regard to the local 
anesthetic dimethisoquin causing enhancement of the rate of 
a process caused by a fluorescent agonist binding to AcChR 
enriched membranes prepared from Torpedo marmbrata. 
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Interestingly, the direction of the effects of dibucaine 
and tetracaine matches their affinities for the high and low 
affinity states of the AcChR site as measured .by [ 3HJ-H 12 -HTX 
binding, an observation first made by Blanchard, et al. (1979a). 
Tetracaine binds relatively more tightly to the low affinity 
form of AcChR and also slows the rate of desensitization. 
Dibucaine increases the rate of desensitization and binds 
relatively more tightly to the high affinity form of the AcChR. 
These authors proposed that the magnitude and direction and a 
local anesthetic's effects on the rate of desensitization may 
be predicted by the ratio of its K1s for the HTX binding site 
in the high and low affinity AcChR states. 
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Table I 
Rates of carbamylcholine induced transition from low agonist 
affinity to high agonist affinity. 
Membranes Alkali Treated 
Membranes 
Carb only .002 .001 - 1 .002 .0005 -1 + s + s - -
+Dibucaine .015 + .002 -1 .010 + .001 -1 s s - -
+Tetracaine .0005 + .0002 -1 .0008 + .0002 -1 s s - -
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Figure 1. SDS polyacrylamide gel scans: 
A. Membrane fragments 





















Figure 2. Assays of the affinity state of the acetylcholine 
receptor for carbamylcholine. 
A) As described in Materials and Methods, membrane 
fragments were assayed for their relative carbamylcholine 
affinity. The plot is of log (X -Xt) vs time, where X 
00 00 
is the amount of a-BuTx bound at equilibrium and Xt is 
the amount of a-BuTx bound at the specified point. The 
TOP LINE represents [ 125 I]-a-BuTx binding without 
presence of carbamylcholine, the MIDDLE LINE represents 
[125IJ-a-BuTx binding when 10- 6 M carbamylcholine is 
added simultaneously with the [ 125 1]-a-BuTx, and the 
BOTTOM LINE represents [125 IJ-a-BuTx binding to the acetyl-
choline receptor which has been desensitized by a 30 min-
-6 ute preincubation with 10 M carbamylcholine. 
B) The affinity state assay described above using alkali 





Figure 3. Change in the rate of carbamylcholine induced 
affinity change in the presence of local anesthetics. 
Membrane fragments which had been treated were incubated 
30 minutes with 50 µM tetracaine (!-!),without local 
anesthetic(•-•), or with 1 µM dibucaine (•-•). 10-6 M 
carbamylcholine was added and the membranes incubated for 
the indicated times before [ 125 1]-a-BuTx was added and 
the rate of complex formation assayed as described in 
Materials and Methods. The plots show the apparent rate 
of toxin binding vs time of incubation with carbamyl-
choline. The rate constants for the transitions were 
calculated as described in the Methods section and are 
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